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FRAMEWORK AND AIMS 
Forensic science is a discipline that combines the knowledge of chemistry, biology, pharmacology, 
statistics, mathematics, physics, and medicine, among others. Statistics is used for different types 
of analysis regarding the certainty of results, regressions, predictions, and probabilities. Mathematics 
and physics are used, for instance, in the determination of bullet trajectories or calculating the 
likelihood of one fingerprint belonging to one person or another. Medicine is applied in the autopsy 
room to determine the time and cause of death, and any other queries related to the body that doctors 
and scientists might need for parallel studies. Chemistry is extensively used in forensic science. 
From the use of infrared (IR) and nuclear magnetic resonance (NMR) for structural characterisation 
of drugs, to the use of chromatographic techniques coupled with mass detection for the elucidation 
of metabolic pathways, or identification and determination of drugs in several biological matrices. 
Also, to establish the elemental composition of gunshot residue (GSR) for identifying the firearm 
used to shoot a person and the distance of the shooter, techniques such as scanning electron 
microscope (SEM) with energy dispersive X-ray spectroscopy (SEM-EDS) are used. 
Spectrophotometry is another important technique that is used, for example, to determine the 
concentration of compounds, such as poisons, dissolved in other liquids. In the area of arson, gas 
chromatography coupled with mass detection (GC-MS/MS) is used, for instance, for the analysis 
and identification of volatile liquids that might have been used as accelerants in arson cases. 
Moreover, techniques such as surface-enhanced Raman spectroscopy (SERS) can be used for the 
identification of explosives from crime scenes debris. In the discipline of environmental forensics, 
techniques such as X-Ray diffraction and ion mobility spectrometry (IMS) can be used for the 
characterisation of soil samples in order to compare them with a soil sample from a cadaver. 
Moreover, IMS is currently used in airport security for the detection of explosives. Entomology and 
botany, two biological disciplines, are also heavily used in forensic science. For example, through 
the study of insects, bugs, plants, and trees, the time of death could be established, as well as the 
discovery of clandestine graveyards. And last but not least, identification of the victim through DNA 
or fingerprints. Forensic science truly is a highly multidisciplinary field. 
This is only a glimpse of all that forensic science encompasses as a discipline. Currently, all areas 
of forensic science require the attention of scientists for improvement, and this doctoral thesis was 
focused on two of them. The first is the estimation of the time of death, which is extremely important 
when bodies are disposed and hidden, where the main methodologies for the estimation of the time 
of death are only useful up to 48 hours. The second one is related to the emerging threat of a new 
type of illicit drugs called novel psychoactive substances (NPS) and the aim is two-fold: metabolic 
pathway elucidation, which is relevant for toxicological risk assessment in order to develop drug 
screening procedures for the detection of drugs and their metabolites in blood or urine and to 
correctly administer an antidote; and the development and validation of a new method for the 
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determination of NPS in hair, which is relevant when some other biological matrices might not be 
available or might not give the necessary information. 
Given all the aforementioned considerations and the emphasis on the multidisciplinary nature of 
forensic science, the aims of the present doctoral thesis are 3-fold: 
 Validation of a capillary electrophoresis (CE) method for the determination of ammonium in 
vitreous humour. Furthermore, to explore the use of potassium and ammonium in vitreous 
humour with different statistical analyses in order to improve the estimation of the post-
mortem interval (PMI) 
 Metabolic pathway elucidation of 5F-APINAC (adamantan-1-yl 1-(5-fluoropentyl)-1H-
indazole- 3-carboxylate), a synthetic cannabinoid which is one of the emerging NPS 
 Development and validation of a fast and sensitive method for the screening of 13 new 
synthetic cannabinoids in human hair  
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CAPILLARY ELECTROPHORESIS (CE) APPLIED TO FORENSIC 
SCIENCE 
1. CAPILLARY ELECTROPHORESIS 
Capillary electrophoresis (CE) is an analytical technique that separates charged molecules in small 
sample volumes quickly and efficiently. Separations take place inside a small capillary due to the 
ion’s differences in electrophoretic mobilities in an electrophoretic environment. Historically, the first 
trial for electrophoretic separation took place in 1886 when Lodge tried to migrate a H+ in a tube of 
phenolphthalein “jelly”. Due to continuous research in chromatography and electrophoresis, the 
technique has evolved to its present form [1]. 
 
Figure 1. Capillary electrophoresis instrumental set-up 
The instrumental set-up is depicted in Figure 1. It generally consists of a capillary (where the 
separation takes place) that goes through the optical centre of a detector; two electrodes made of 
platinum, the anode and cathode; an autosampler; a high voltage power supply; and two buffer 
reservoirs to submerge the electrodes and capillary. For separation to take place, the capillary is 
filled with the buffer solution, then the sample is injected, and voltage is applied. This causes 
electroendosmotic and electrophoretic movements which result in the sample moving towards the 
cathode passing through the detector [2].  
The most used capillaries are fused silica with an external polyamide coating to protect them and 
with internal diameters between 20-100 µm. On the inner wall silanol groups are present. One of the 
main advantages of the CE is that only very little sample is injected (to the order of nL) due to small 
volume of the capillary column and this represents a great advantage particularly when dealing with 




1.1.1 ELECTROPHORESIS AND ELECTROOSMOTIC FLOW 
The electrophoresis movement is the process by which ions move from one electrode to the other 
due to the applied voltage. The ion’s mobility (migration rate) is ruled by the number of ionic charges 
and its size (Eq.(1)). 




where µ𝐸  is electrophoretic mobility, 𝑞 is number of charges, 𝜂 is solution viscosity, and 𝑟 is the 
radius of the ion. Therefore, when separating a mixture of ions, the larger ones with less charge will 
be the slowest to reach the detector, whereas the smaller, highly charged ions will be the first ones 
to be detected. As an example, if two ions have the same number of charges, the bigger ion will 
move slower than the small one [2]. 
Another phenomenon caused by the application of high voltage into the capillary is electroosmotic 
flow (EOF). When the acidic silanol groups inside the capillary come in contact with the buffer 
solution, they are ionised and EOF is created, driving the solute towards the detector (Eq.(2)).  




where µ𝐸𝑂𝐹 is EOF mobility, ԑ is the buffer dielectric constant,  𝜁 is the charge on the surface of the 





Figure 2. 2A: Schematic diagram of capillary surface and of EOF generation. 2B: Migration of 
analyte in the presence of EOF. The migration velocity of a given species can be expressed as a 
vector sum of  the EOF(µ𝐸𝑂𝐹) and the electrophoretic mobility (µ𝐸) of the solute (adapted from [3]). 
When the separation buffer’s pH is higher than 4, the silanol groups start to be ionised, leading to 
the formation of a negatively charged layer. In order to maintain electroneutrality, a cation layer is 




The main parameter affecting the level of EOF is the pH of the electrolyte. At high pH (above 9), the 
EOF is strong because the silanol groups are fully ionised, whereas at low pH (below 4), the EOF is 
weak because they are barely ionised. The overall migration time of an ion (apparent mobility µ𝐴) is 
a sum of the EOF (µ𝐸𝑂𝐹) and the electrophoretic mobility (µ𝐸) of the solute (Eq.(3)) [2],[3]. 
(3)                 µ𝐴 = µ𝐸 + µ𝐸𝑂𝐹  
1.1.2 SAMPLE INJECTION 
There are three mechanisms for introducing the sample: electrokinetic, gravity, and hydrodynamic. 
All three involve the application of a force to inject the sample in the capillary while it is immersed in 
the sample solution.  
In electrokinetic injection, both the capillary and electrode are placed in the sample vial. It is based 
on the application of a high voltage at the tip of the capillary causing solute ions to enter by EOF and 
electrophoretic migration. With this method a greater number of ions enter the capillary which is an 
advantage when trying to quantify trace levels of small ions, but it can also be disadvantageous since 
it can cause sample bias effects (more mobile species are injected in larger quantities).  
Meanwhile, gravity injection is based on mechanically raising the capillary above the height of the 
detector electrolyte vial.  
Finally, the hydrodynamic method is based on a pressure differential. While the capillary is immersed 
in the sample solution, a pressure difference is applied either in the form of vacuum or positive 
pressure. In order to ensure sample injection reproducibility, maintaining a constant temperature is 
needed [1,2]. 
1.1.3 PEAK EFFICIENCY 
One mayor advantage of CE is the minimisation of band broadening effects, which represent a major 
issue in HPLC and conventional electrophoresis. Sample dispersion along the capillary is minimised 
due to the  EOF flow dynamics in comparison with the  laminar flow of  pump systems; convection 
related band broadening (typical in conventional electrophoresis) is reduced  because the heat 
generated due to the voltage application is dissipated through the capillary walls (Joule heating); and 
post-separation broadening is eliminated due to on-column detection [2]. 
1.2 ANALYTICAL CONDITIONS 
1.3 SEPARATION TECHNIQUES 
As mentioned before, the separation in CE takes place due to electric charge differences in the ions 
of interest. It may seem that CE is only suitable for ionic molecules, however, by including proper 
additives into the background electrolyte it is possible to convert non-ionic analytes into charged 
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species, thus allowing for their separation in CE. The five most common CE separation modes are 
explained below. 
1.3.1 CAPILLARY ZONE ELECTROPHORESIS (CZE) 
CZE is the most common separation technique. In this technique, separation is achieved through 
the solutes’ migration in the buffer inside the capillary, which depends on their own electric mobility. 
The main factors affecting separation are: pH, conductivity, temperature, ionic strength of the 
solution, presence of additives and length of the capillary. UV detection can be done indirectly or 
directly, with indirect detection offering higher sensitivity for some compounds. For indirect detection 
of cations, such as ammonium, a strong absorbing molecule like imidazole can be used as a UV 
absorbent. In addition, chelating agents such as crown ethers can be added to the background 
electrolyte to improve separation since they can interact with the ions [3]. 
1.3.2 MICELLAR ELECTROKINETIC CHROMATOGRAPHY (MEKC) 
Aiming to tackle a serious limitation of CE, which is the necessity of the substance to be charged, 
MECK was created allowing neutral and charged analytes to be separated. This is achieved through 
the use of micellar solutions of ionic surfactants. An ionic surfactant solution with a concentration 
higher than its critical micelle concentration (CMC) is added to the buffer so that micelles are formed. 
The surfactant added can be either cationic or anionic. If a cationic surfactant is added, the EOF 
migrates towards the positive electrode (anode) and the micelle migrates to the negative electrode 
(cathode). If the surfactant added is anionic, the micelle migrates to the positive electrode by 
electrophoresis and the EOF flows toward the negative electrode due to the negative charge of the 
capillary surface [2].  
1.3.3 CAPILLARY GEL ELECTROPHORESIS (CGE) 
In CGE, the analytes migrate through polymer networks (acting as sieves) at different speeds 
depending on their molecular sizes. CGE possesses a number of potential advantages such as the 
prevention of analyte adsorption in the capillary walls, minimisation of solute diffusion, and 
elimination of electroosmosis. Altogether, these increase column resolution in short columns and 
can be a highly sensitive method if used with laser-induced fluorescence detectors. The most widely 
used capillaries are polyacrylamide and agarose filled capillaries [1,3].  
1.3.4 CAPILLARY ISOTACHOPHORESIS (CITP) 
In this technique, a leading electrolyte is added to the background buffer. First, a large volume of 
sample dissolved in the leading electrolyte is injected into the column. Then, the injection end of the 
capillary is submerged in a solution containing a terminating electrolyte and then voltage is applied 
during a set amount of time in order to focus the sample in bands (analyte zones) which are 
continuously formed. Finally, the capillary is submerged in the support buffer solution and voltage is 
11 
 
applied to separate the sample by standard CE separation. The separated zones can be detected 
by using a potential gradient or a conductivity detector [2,3].  
1.3.5 CAPILLARY ELECTROCHROMATOGRAPHY (CEC) 
Capillary electrochromatography was developed as a hybrid between chromatography and 
electrophoresis. In CEC, a chromatographic stationary phase is introduced in an electrophoretic 
environment either as a film in the walls of the capillary or as a packed bed. In this technique, neutral 
species will be separated without the necessity for any additives, whereas ionic species will be 
superimposed on the electrophoretic separation [2]. 
1.4 FORENSIC APPLICATIONS OF CE 
CE has gained popularity in the forensic field due to its clear advantages, such as minimal sample 
injection, speed, high mass sensitivity, low consumption of solvents, low cost, and its suitability to 
be coupled with mass detection. Substances analysed with CE techniques vary from DNA fragments 
to inorganic ions [4]. Some examples of its broad applicability in this field are discussed.  
In the area of illicit drugs, Porpiglia et al.[5], used CZE for the chiral determination of ketamine and 
norketamine (its major metabolite) in hair. They used cyclodextrins and electrokinetic injection. 
Airado-Rodríguez et al.[4], developed a method for the analysis of lysergic acid diethylamide and its 
C-8 isomer in hair samples with CZE. Evans et al.[6], used a portable CE instrument to determine 
the inorganic ionic profiles of three pharmaceutical samples and precursors of two illicit drugs: 
methylone and para-methoxymethamphetamine. Gottardo et al.[7], developed a CE-ESI-TOF 
method for the determination of illicit and controlled drugs in blood using CZE and electrokinetic 
injection. Concerning fire arms debris analysis, Northdrop et al.[8], used MECK for the separation 
and identification of organic gunshot residue and explosive constituents. Erol et al.[9], determined 
amounts of nitrite and nitrate in gunshot residue by CZE. Regarding forensic toxicology, Tagliaro et 
al.[10], developed and validated a new method for the determination of potassium in vitreous humour 
and its use as an estimator of the post-mortem interval (PMI) with CZE. Furthermore, the 
determination of Carbohydrate-Deficient Transferrin (CDT), which is a marker of alcohol abuse, is 
one of the major applications of CZE. A lot of research has been done by the research group of F. 
Tagliaro on the determination of CDT with CZE with improvements in sample treatment and cost-
effectiveness in comparison with HPLC determination [11–14]. Regarding counterfeit investigations 
of documents, ink and dyes can be analysed by MECK. CE replaced HPLC due to its very good 
performance distinguishing between water-soluble inks that contain ionic dyestuffs. Inks coming from 
different manufacturers and different countries give different patterns in the electropherograms [15]. 
CE can also be applied to investigations of clandestine laboratories. Hauser et al.[16], developed 
and validated a CE method for the quantification of ammonium, chloride, sodium, sulphate and 
formate ions, which are present in clandestine production of amphetamine. Wright et al.[17], recently 
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developed a CE with laser-induced fluorescence detection methodology for the fast and reliable 
analysis of sexual assault kits (SAKs). 
Further applications include analysis of forensic DNA with multicapillary electrophoresis with 
fluorescent detection and analysis of ions and small molecules for investigations in intentional 
poisoning (cyanide) or fire and arson investigations [18].  
13 
 
2. STATISTICS AND CHEMOMETRICS IN FORENSIC SCIENCE 
In forensic science, where the results of the examination of complicated evidence must lead to 
unbiased verdicts in legal proceedings, it is of high importance to correctly identify and assess 
samples. To do so, analytical methods such as liquid and gas chromatography or capillary 
electrophoresis are used in combination with statistical analysis. For instance, in clinical chemistry, 
many analytes can be determined in a sample of vitreous humour, blood, or urine yielding 
multivariate data for one specimen. Hence, some samples might produce more complex data than 
others which requires more sophisticated statistical methods. To overcome such difficulty, advanced 
chemometric methods can deal with complex and large datasets. By definition, chemometrics 
“extract the maximum valuable information from the dataset by using the best measurement 
techniques/ optimal procedures and acquires most of the chemical information from the sample data. 
It correlates quality parameters or physical properties of the data”. Indeed, chemometrics, or 
multivariate statistics, extracts the information from spectra obtained by analytical methods and it 
analyses the data through chemical pattern recognition. This supervised pattern recognition method 
constructs a model based on information of known samples and uses the model to further predict 
unknown samples. For each sample, there are two groups of variables: predictors and response. 
Finding a relationship between these two variables is key to obtain information from unknown 
samples. There are different types of analysis to apply, such as k-nearest neighbour (kNN), partial-
least-squares discriminant analysis (PLS-DA) and artificial neural networks (ANN) [19,20].  
2.1 ARTIFICIAL NEURAL NETWORKS (ANNS) 
ANNs is a genetic algorithm, an attempt to make a computer model of the brain. The algorithm works 
by processing a selection of initial data then generating an output that is tested for its accuracy. This 
process undergoes multiple iterations until an acceptable outcome is produced. Once the data is in 
the system, ANNs imitate the neurons in the brain (Figure 3) trying to figure out the relationships 
within the data. Through the dendrites, neurons receive input signals and send them out through the 
axon, and release neurotransmitters to pass them on to other neurons. If the strength of the inputs 
is not enough to overcome a threshold value, a signal is not produced in the axon. Similarly, ANNs 
have layers of interlinked artificial neurons (nodes), akin to processors that work in parallel. The 
measured data is given to the input layer, and through a series of mathematical operations in the 
hidden layers, the output is generated. In more detail, the network is interactively trained with a set 
of data.  
In the current project, using the peak information of the analytes and the known post-mortem interval 
(PMI), the network will predict a PMI for each sample and compare it to the known PMI. Any 
differences between the known PMI and the network’s output will be used to adjust the internal 
parameters (in the hidden layer). This process will continue until the required degree of accuracy is 
achieved, which is evaluated with a test set. The network can be over-fitted if one forgets the fact 
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that the test and training sets will differ to some degree. If the network is over-fitted, it will perform 
extremely well in the training set, not so well in the test set, and badly in the unknown samples. Thus, 
the aim of most networks is to perform some type of data modelling and they can do it in two ways: 
under supervised and unsupervised conditions. Supervised networks attempt to learn a relationship 
between data and a parameter, whereas unsupervised networks try to find natural clusters 
irrespective of external restrictions [19–21].  
The most important type of supervised learning networks is a feedforward multilayer perceptron or 
multilayer perceptron (MLP), shown in Figure 3 . The data flows forward and there is a defined input 
and output. As seen in Figure 3, the input data is fed to the nodes in the first hidden layer, which 
forms a weighted sum of the inputs and passes that sum through a non-linear transfer function, and 
the values are then sent to the nodes in the second hidden layer which then performs a similar 
operation, and the outputs are generated. In the end, the network output is the sum of its inputs [21]. 
The focus of the project will be in MLP, using it as a regression tool. 
Neural networks can be used for pattern recognition, modelling, classification, and multivariate data 
analysis (i.e. regression) purposes [22]. As it can be seen, ANNs are great tools for multivariate data 
analysis since they possess extremely good information processing features, as presented in Table 
1.  
Table 1. Advantages and limitations of ANNs 
Advantages Limitations 
 Generalisation: the application of the created 
model to untrained (or unknown) data 
 Learning adaptability: the network changes its 
structure in response to a shifting environment 
 It is not necessary to know the relationship 
between input and output data, the network 
learns that relationship through training 
 Better fitting of the data: the network decides 
the function that relates the input and output 
data, either linear or non-linear. It decides 
based on the amount of training received 
 Noise insensitivity: It can make accurate 
predictions in the case of measurement errors 
and uncertain data 
 High parallelism (nodes) implies fast 
processing 
 The quality of the network depends on the 
amount and quality of the input data. Large 
datasets are desirable since it provides more 
information for training and testing, leading to 
better final network quality 
 There is no way to estimate confidence 
intervals 
 The computing power depends on the 




Figure 3. Comparison between a neuron and ANNs. The ANN has two layers, with 4 nodes each 
and several inputs and outputs. Adapted from Bailer-Jones et al.[21]. 
Even keeping into consideration their limitations, ANNs still represent a powerful tool in many fields 
[19,22] 
2.1.1 NETWORK TRAINING 
It is important to point out that the network does not create a new regression, rather, it interpolates 
the training data to generalise a relationship between the input data and the target (known outputs). 
In order for the network to create accurate outputs, the weights (free parameters of the network) 
need to be set to fitting values and this is done by training the network. MLP progresses by 
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minimising the error function with regard to all the network weights. For each node h, the sum value 
is obtained, according to Eq. 4: 
(4) 𝑠𝑢𝑚ℎ =  ∑ 𝑥𝑓𝑤𝑓ℎ + 𝛾ℎ𝑓  
Where, 𝑤𝑓ℎ is the product of each connection weighting from node f to node h, 𝑥𝑓 is the input, and 𝛾ℎ 
is the bias value. This is later transformed with a transfer function (identity, sigmoid, hyperbolic 
tangent, and rectified linear unit) which is then used for the output. Since the aim of training is to 
minimise the error by changing the weights between layers, the back-propagation algorithm is used 
for this purpose, i.e. to adjust the weights according to error (E), Eq. 5: 
(5)          𝐸 =
1
2




Where 𝐸 is the error of the network, 𝑦 are the sum of the output values over p training pattern and f 
output nodes, and 𝑡𝑝𝑓 are the target values (desired output). Then, the error is minimised according 
to a function for weight optimisation (stochastic gradient descent, stochastic gradient descent-based 
optimiser and Broyden–Fletcher–Goldfarb–Shanno). This represents the learning process, which is 
iterative, and goes on until the network converges, i.e. the error reaches a minimum. As mentioned 
before, the aim of the network is to generalise an answer, not to memorise the training data (over-
fit). In order to solve this, a regularisation technique is used [21,23].  The most common technique 
used is regularisation by weight decay (denominated as alpha, α), which penalises large weights to 
prevent them from counting more than smaller weights. A larger weight might be mistaken as more 
important, which can lead to over-fitting [24]. 
2.1.1.1 ACTIVATION FUNCTIONS FOR THE HIDDEN LAYERS 
The activation function transforms 𝑠𝑢𝑚ℎ to determine the outputs. The activation functions for the 
hidden layer are: 
 Identity: 𝐹(𝑥) = 𝑥, it takes the arguments and returns them unchanged 
 Sigmoid: 𝐹(𝑥) =  
1
(1+𝑒−𝑥)
, it takes the arguments and transforms them in the range of (0,1) 
 Hyperbolic tangent: 𝐹(𝑥) = tanh (𝑥), it takes the arguments and transforms them in the range 
(-1,1) 
 Rectified linear unit: 𝐹(𝑥) = max (0, 𝑥), used for categorical variables. 
Conversely, the advantages of choosing one function over another is not yet understood. Hence, the 
way of knowing which function better suits the data is by trial and error [22,25]. 
2.1.1.2 SOLVERS FOR WEIGHT OPTIMISATION 
The error in Eq.5 is minimised using algorithms. There are three possibilities: 
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 Stochastic Gradient Descent (SGD). Using gradient descent for weight optimisation, the 
network stops once it reaches a minimum. However, this could be a local minimum and not 
a global one. An element called momentum (µ) is added to the weight updates, which is a 
parameter that allows to break from the local minima. Conversely, it might lead to slower 
convergence. Another element is the learning rate (η) which controls the weight’s update 
speed. If a small learning rate is selected, the search towards the global minimum will be 
slow but steady, and the network might take a very long time to converge. If the learning rate 
is high, the weight vector will vary greatly from one cycle to another and might cause the 
network to waver around the global minimum but never converge. Thus, during learning, it is 
key to observe the effects of learning rate and momentum. Gradient descent is the most 
frequently used solver due to ease of coding, but might not always be the most suitable option 
[22]. 
 Adam: Stochastic Gradient Descent-based optimiser, based on adaptive moment estimation. 
It combines the advantages of two extensions of the SGD algorithm and the little tuning 
needed by the hyperparameters. Based on how quickly the weights are changing, the 
parameters’ learning rates are adapted [26]. 
 Broyden–Fletcher–Goldfarb–Shanno (L-BFGS). Used for solving nonlinear optimisation 
problems. Instead of using a gradient descent direction, the best descent direction is used 
[27].  
2.1.2 SOFTWARE 
Several possibilities exist for the creation of ANNs. The easiest one is through the use of statistical 
software which has pre-installed ANN analysis, such as SPSS. The main advantage is the user-
friendly display when it comes to adjusting the settings of the networks and the analysis of the results. 
Conversely, not all parameters can be selected/unselected and it might not be updated with the 
latest developments in machine learning, which can be a major drawback. In addition, this statistical 
software uses fit-them-all basic settings which may not always suit the needs of the user [28]. 
Another option is MATLAB, a hybrid between a statistical program and pure coding, with cost being 
the main limitation [29]. Another possibility is Python [30]. Its main advantage is that it is open-source, 
and all additions, libraries, and extensions are free as well. In addition, it has great support and an 
online database for coders (Stackoverflow).  
2.1.3 APPLICATIONS OF ANNS IN FORENSIC SCIENCE 
In the forensic toxicology area, two studies combined the use of ANN with instrumental analytical 
methods. Bocaz-Beneventi et al.[23], optimised a CE method with ANN for the accurate 
determination of the post-mortem interval using the data from ammonium, potassium, and sodium 
as input variables, with PMI as the output. They used the TRAJAN programme, which is an ANN 
simulator, and the network was built for regression purposes. Butcher et al.[31], used GC-MS to 
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analyse larvae and a classification neural network to estimate the age of the larvae to help determine 
the PMI. Broséus et al.[32], used a neural network classifier to determine the ability of the ANN to 
classify different cannabis seeds. In the field of digital forensics, Rodríguez et al.[33], compared the 
performance of facial comparison software with experts to assess whether the use of software can 
aid experts in court. They used convolutional neural networks through open-source software. Del 
Espiritu et al.[34], used ANN for the identification of total and partial fingerprints. They built a 
classification ANN using SGD as a solver.  Grantham et al.[35], developed a new algorithm for use 
with classifier neural networks for helping with geolocation in a crime scene. Forensic anthropology 
is also a field with some ANN applications. For example, Hemalatha and Rajkumar [36], developed 
an approach for dental age estimation, and Prescher et al.[37], developed one for the 
characterisation of anthropological features of nose variability, with both using classifier neural 
networks. In fire investigations, Zong et al.[38], were able to identify soot sources analysed by GC-
MS using principal component analysis (PCA) and inputting the data to a classifier neural network. 
Casamento et al.[39], optimised a CE methodology with ANN for the separation of organic 
explosives. The pH and concentration of SDS were the input variables and the explosive’s mobility 
were the output variables. As it can be seen, the classification ANNs are more used in comparison 




3. ESTIMATION OF THE POST-MORTEM INTERVAL (PMI) THROUGH THE 
DETECTION OF NH4+ AND K+ IN VITREOUS HUMOUR WITH CE 
3.1 INTRODUCTION 
In modern forensic medicine, the estimation of time since death has been and still is one of the major 
open issues, making it one of the most attractive research subjects. In criminal investigation, the 
accurate estimation of the post-mortem interval (PMI), and consequently, of the time of death, often 
close to the time of the murder, helps to reduce the number of suspects, to support (or deny) the 
witnesses’ statements, and to verify the reported actions of the suspects of a crime. Because of the 
highest importance of an accurate estimation of the time of death by objective methods, a large body 
of literature has accumulated in the past decades, as witnessed by numerous scientific papers and 
reviews [40–45] and specific books [40,46].  
The determination of the PMI is traditionally based on the evaluation of post-mortem physical 
changes in the body, and more recently, on post-mortem chemistry. Post-mortem changes in the so-
called ‘early post-mortem period’ (usually defined as the time between death and the appearance of 
generalised putrefaction) comprise rigor mortis, lividities, body cooling, stomach emptying, and in 
some cases, the so-called supravital phenomena. This approach, however, has important flaws, 
including high inter-individual variability, and a time window of application limited to 24–48 hours 
since death. In particular, lividities and rigor mortis also suffer from subjectivity of recording, which 
largely depends on the experience of the forensic pathologist. Concerning body cooling, the 
environmental temperature, clothing, posture, shielding against the supporting surface, body 
temperature before death, body dimensions, etc. are all factors that influence the phenomenon and 
limit substantially its reliability in real cases [45]. As a matter of fact, notwithstanding a plethora of 
papers on the optimisation of this approach, the calculation of PMI based on body temperature still 
shows important limits in terms of accuracy [40]. Moreover, the equilibration of the body temperature 
with the environment is almost completed within the first 20 hours after death, which limits the time 
window of applicability of the method.  In relation to stomach emptying, the nature of the food, 
systemic or nervous shock, or stress and the continuation of digestion after death are all factors that 
make it a weak indicator. Moreover, the chronology of stomach emptying can be used to determine 
the time of death only if the time of the last ingestion of food is precisely known [40,45]. 
In contrast, post-mortem chemistry, known as thanatochemistry, is based on the analysis of the 
modifications of the concentrations of endogenous compounds, which are released, produced, or 
transformed in the body after death. Contrary to the approach based on body cooling, 
thanatochemistry allows for the estimation of the time of death for up to 100 hours and more [40]. 
Among the biological samples used so far, vitreous humour is, in principle, the most promising due 
to its isolation and protection from the environment and easy sampling when compared to blood or 
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cerebrospinal fluid [41]. Furthermore, it was found that vitreous humour, in most instances, is barely 
contaminated by external agents even in the late PMIs. Numerous post-mortem chemical 
compounds such as potassium, chloride, sodium, magnesium, calcium, phosphate, creatinine, 
lactate, and urea were investigated in the vitreous humour [42]. Among these different parameters, 
the most studied by far is potassium. Its concentration in the ocular fluid increases after death due 
to the passive release of intracellular potassium into the vitreous body (substantially an extracellular 
fluid), until the equilibrium between the extra and intracellular compartments is reached [40]. Since 
the early ‘60s until present, many studies have identified this increase as one of the main parameters 
for inferring the PMI [10,43,44,47,48]. However, discrepancies among researches have been 
reported when examining the linear relationship potassium-PMI with regard to the intercept and the 
slope of the regression lines, which have severely limited the practical application of the method [10]. 
These discrepancies can be attributed to several factors such as different causes of death, different 
storage conditions of the bodies, different modes of sample collection, but above all, to the different 
analytical techniques used by the authors, most of which were validated for clinical chemistry, but 
not for post-mortem chemistry [49].  
The analytical techniques applied to vitreous humour can be divided into two categories: non-
separation and separation methods. Non-separation methods include flame photometry and ion-
selective electrodes, whereas separation methods include ion chromatography (IC) and capillary 
electrophoresis (CE) [10,47,50]. Non-separation analytical techniques are widely accepted in the 
clinical environment for the analysis of serum and urine (mostly based on ion selective electrodes), 
but are more susceptible to interferences due to the matrix composition, as compared to separation 
techniques [48]. This limitation applies particularly to cadaveric fluids, the composition of which is 
typically non-standardised and affected by numerous variables, the most important of which is 
putrefaction. On the other hand, among separation techniques, capillary electrophoresis (CE) is 
known for its selectivity, low sample consumption, high efficiency, resolution, and speed. 
Furthermore, CE, lacking a packed column (as IC) which can easily be clogged or contaminated, 
can tolerate “dirty” samples, such as cadaveric fluids. In fact, CE was used for the analysis of 
potassium in vitreous humour with very encouraging results, allowing for the direct injection of diluted 
vitreous humour micro samples [10,48]. On the other hand, Zhou et al.[47], using low pressure IC 
fitted with a self-made conductivity detector, also reported promising results, but the application to 
real cases was limited to PMIs up to 27 hours. 
On the basis of the above considerations and personal experience with potassium analysis, CE was 
chosen in an attempt to study other ions in the vitreous humour, specifically ammonium. This ion, a 
typical product of post-mortem protein deamination, has long been almost neglected, probably due 
to the well-known problems for its analysis in clinical chemistry [51]. To the best of our knowledge, 
only a single paper appeared in 1978 reporting ammonium determination in the vitreous humour. 
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For this purpose, a colorimetric method was used based on Nessler's reagent. The results, although 
obtained with an outdated non-separation method, look quite promising [52].  
Taking into account the above-mentioned considerations, a CE method for the determination of 
ammonium in the vitreous humour has been developed and validated with the aim of providing a 
new and reliable tool for thanatochemical studies.  Further aims of the research were to carry out a 
preliminary investigation on the behaviour of ammonium concentrations in the vitreous humour of 
real cases, and given positive results, to further study its applicability and usefulness alone and in 
combination with potassium to achieve more reliable estimation, by thorough statistical analysis of 
the post-mortem interval, and consequently, of the time of death. In addition, the present work also 
includes a specific study aimed at verifying the consistency of the post-mortem increase of 
ammonium concentrations in the vitreous humour by comparing the results from the two eyes at the 
same time after death. 
3.2 MATERIALS AND METHODS 
3.2.1 CHEMICALS  
All chemicals were analytical-reagent grade. Imidazole (99% pure) was obtained from Sigma (St. 
Louis, MO, USA), 18-crown-6 ether (99% pure) and α-hydroxybutyric acid (HIBA) (99% pure) from 
Aldrich (Milan, Italy). Standard solutions of ammonium (NH4+) and barium (Ba2+) were prepared from 
AnalaR salts (NH4Cl and BaCl2) (Merck, Darmstadt, Germany). The electrophoretic buffer pH was 
adjusted to the desired pH with glacial Acetic Acid (Merck, Germany). Ultrapure water (milliQ) was 
obtained using a water purification system Purelab Chorus (Elga Veolia, High Wycombe, UK). 
3.2.2 CE SYSTEM AND SOFTWARE 
All experiments were performed using a P/ACE MDQ Capillary Electrophoresis System (Beckman, 
Fullerton, CA, USA) equipped with a UV filter detector. The capillary was thermostated with a 
perfluorinated coolant flowing in the capillary cartridge. During all experiments, untreated fused-silica 
capillaries (75 μm I.D., 50 cm effective length; Beckman) were used with a detection window of 
200x100 μm. Beckman P/ACE Station (version 8.0) was used for instrument control, data acquisition, 
and processing. 
3.2.3 ELECTROPHORETIC CONDITIONS 
Electrophoretic separations were performed using a running buffer consisting of 6 mM HIBA, 5 mM 
18-crown-6 ether, and 5 mM imidazole adjusted to pH 4.5. Constant voltage runs were performed in 
all experiments by applying a voltage of 500 V/cm at 25ºC with a resulting current of about 18 μA. 
The separation took place at 25 kV for 4 minutes. To overcome the lack of optical absorbance of 
ammonium, the ions were detected using indirect UV detection at 214 nm. The analytes were 
injected at the anodic end of the capillary for 10 s at 0.5 psi. The capillary was conditioned every day 
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with a solution containing 1 M NaOH (20 min) followed by water (15 min) and finally with the running 
buffer (10 min). Between consecutive runs the capillary was washed with water (3 min) and then with 
the running buffer (2 min). Water blanks were routinely checked for contamination with trace amounts 
of cations. 
3.2.4 PREPARATION OF STANDARDS AND SAMPLES 
All solutions were prepared in polypropylene vials. A 100 mM stock solution of NH4+ was prepared 
by dissolving adequate amount of NH4Cl in milliQ water. Ammonium working standard solution was 
prepared daily to the desired concentration by diluting with water. BaCl2 internal standard (IS) 
solution was prepared by dissolving the appropriately weighed amount to achieve a final 
concentration of 40 μg/mL.  
Vitreous humour samples were collected from a total of 38 medico-legal autopsies or external 
examination of corpses of violent or sudden deaths, in which the time of death was exactly known 
(Appendix I. 6.1.1 List of vitreous humour samples used for the study). The causes of death included 
mostly road accidents and other traumas. For the linear and polynomial approaches, samples with 
low PMIs were not considered. The vitreous humour samples were prepared by diluting 1:20 with 
the IS solution.  Samples were analysed in triplicate. Because of the lack of recent deaths at the time 
of the present work and considering only the preliminary application of the method to the study of 
real forensic cases, most of the samples analysed had been stored at -24ºC for several months (up 
to 5 months) before analysis. 
3.2.5 METHOD VALIDATION 
The analytical method presented was developed based on a previous study on the determination of 
potassium in vitreous humour [10], where a peak attributed to ammonium could only be identified, 
but never formally studied [47]. Therefore, the present work was conducted for the optimisation and 
validation of ammonium determination by considering the following parameters: precision, bias, 
linearity, sensitivity and selectivity.  
The optimization and validation of methods is a way to establish if they meet the analytical 
requirements for which they were designed. It evaluates the method’s capability to be used in a 
specific application. Method development and validation are intertwined since the method 
performance characteristics are also considered when a method is validated. Method validation is a 
necessity since many methods are used to make conclusions, for example how long a person has 
been dead. Therefore, it is of high importance to produce accurate results. The performance 
parameters evaluated in method optimization and validation for quantitative methods are as follow: 
bias (trueness), precision, limit of detection (LOD), limit of quantification (LOQ), working range 
(linearity) and selectivity [53]. Precision and bias studies can be carried out simultaneously since 
both should be assessed at three different concentration levels (low, middle and high) and be 
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evaluated for at least 3 days. Precision results are expressed by the analytical reproducibility 
(RSD%) and are an indication of how reproducible the results are in the same day on different runs 
and over time (5 days or more). The RSD values should be within ±15%. Bias is expressed with the 
analytical bias (%) and it is an indication of the error between the measured value and the true value. 
The values should be between ±15% for methods using biological matrices. The linearity is the range 
of analyte concentrations in which the method will be used. It is highly important to correctly establish 
the working limits of this linearity range, otherwise accurate results might not be obtained. The most 
common approach is a linear regression. LOD and LOQ are also evaluated parallel to linearity. LOD 
is the lowest concentration of analyte that can be measured with statistical certainty and the LOQ is 
the lowest concentration of analyte that can be quantified with a suitable level of trueness and 
precision. Selectivity indicates the ability of the method to correctly identify the analyte, in the 
presence of other compounds. There are several ways to evaluate it, but the relevant one for this 
work is using complexing agents [54,55].  
In CE, complexing agents are substances added in the electrolyte solution to shift migration times in 
the case of cations with similar electrophoretic mobilities. Lactic acid and crown ethers are two 
common examples. Specifically, crown ethers have been used successfully for the electrophoretic 
separation of NH4+ and K+ [56–58]. The crown ether interacts with K+ and slows its migration time. 
The specific complexing mechanism is based on the relationship between the cavity size of the 
crown ether and the radius of the cations. Precisely, the 18-Crown-6 ether has a radius of 1.58 Å 
and the ionic radius of K+ is 1.58 Å, whereas the radius of NH4+ is 1.51 Å. Therefore, potassium fits 
perfectly well inside the crown ether and its migration time is slowed allowing for a separation from 
the NH4+ [56]. In this work, two complexing agents have been combined, namely HIBA and 18-
Crown-6 ether. In this case HIBA does not complex NH4+ and K+  but modifies the mobility of Ba2+ 
[59]. For the present study, the constituents of the background electrolyte have been adapted from 
a previously developed CE methodology for the determination of K+ in vitreous humour [10]. 
3.2.6 STATISTICAL ANALYSIS 
To better tune the usefulness and accuracy of the present validated method, three different statistical 
methods were performed. Firstly, preliminary results were fitted to a linear method. Secondly, to 
increase correlation and accuracy of predictions, the logarithmic correlation was explored. Finally, to 
further improve PMI estimation, ANNs were performed in the final data (obtaining a multivariate 
statistical analysis). Linearity and logarithmic analysis were done using Microsoft Excel 2013 
software. The ANNs analysis was performed using Scikit-learn module (0.23.2) MLPRegressor [25] 
in Jupyter Notebook environment (version 6.0.3), from the Anaconda Navigator (anaconda3) [60]. 
Data was manipulated with Pandas and Numpy [25]. The code was written with Python 3.8.  
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3.3 RESULTS AND DISCUSSION 
The previously described procedures have been applied to the data. The most relevant results are 
discussed. 
3.3.1 PRECISION: INTRA- AND INTER-DAY STUDIES 
The intra-day precision was verified at three concentration levels (low, middle, and high). The 
standards were diluted 1:20 with IS. Seven injections were made for each concentration level. To 
calculate the inter-day precision, determinations were performed on three different non-consecutive 
days. In addition, the stability and reproducibility in authentic vitreous humour matrix was studied.  
Table 2. Reproducibility (RSD%) of the CZE analysis of ammonium in standard solutions (n=3) 
tested in three different days. 






Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 
5 2.12 0.74 1.64 7.32 0.54 0.48 0.81 2.44 
1.25 8.28 3.53 5.82 11.43 0.56 0.46 0.20 3.99 
0.31 3.28 6.78 5.48 18.51 0.44 0.61 0.39 3.81 
Three real samples were selected and analysed over a period of 5 days with 5 injections per sample. 
In all the studies, the concentration of the NH4+, as well as the migration time of this ion were recorded 
and statistically analysed in terms of Relative Standard Deviation (%RSD). The results of the Intra- 
and inter-day precision studies carried out on the ammonium standard solutions are summarised in 
Table 2, and those from real samples are presented in Table 3. From both the tables, the results 
show that in all cases, the analytical precision was acceptable, with %RSDs well below 20%, even 
in real biological samples. 
Table 3. Analytical reproducibility (RSD%) of CZE analysis of ammonium in vitreous humour (n=3) 






Relative area RSD (%) 
 Intra-day Inter-day 
Sample number Day 1 Day 2 Day 3 Day 4 Day 5  
1 7.03 5.89 6.12 4.14 5.02 12.90 
2 8.40 2.91 6.50 7.52 4.62 4.40 
3 9.93 4.51 5.38 2.68 1.34 4.88 
Relative migration time RSD (%) 
1 1.70 0.28 0.49 0.57 0.16 1.04 
2 0.48 0.20 0.18 3.47 0.20 1.98 




Bias was calculated at three different concentrations (0.312, 1.25, and 5.0 mM). However, in order 
to also study the analytical bias in real matrix, a standard addition experiment was performed, by 
spiking known amounts of NH4+ standard (15 and 10 mM) into real vitreous humour samples. Bias 
was calculated according to the formulas reported by the Scientific Woking Group for Forensic 
Toxicology (SWGTOX) [54]. The bias results from the spiking test were -1.24 % and 7.13 % for 15 
and 10 mM, respectively. Overall, the bias was fairly acceptable as shown in Table 4. 





3.3.3 LINEARITY, LOD, AND LOQ 
For the linearity studies, 5 vials with increasing NH4+ concentrations were measured at the following 
concentrations: 0.16, 0.31, 0.63, 1.25, 2.5, and 5.0 mM. Each concentration level was measured in 
duplicates. A calibration curve was obtained by plotting the relative peak area (NH4+/IS) against the 
concentration of ammonium (Figure 4).  
 
Figure 4. Linear calibration curve obtained by plotting the relative peak area (NH4+ /IS) against the 
concentration of NH4+ (mM). 
The results were linearly correlated according to the equation y = (0.0357±0.0008 SD) x + 
(0.033±0.002 SD); r2 = 0.998 (y = relative peak area; x = concentration of NH4+ in mM). The limit of 
















Bias (%) of the relative area 
Concentration (mM) Day 1 Day 2 Day 3 
5 0.93 0.75 -0.49 
1.25 -1.65 -0.45 -5.37 
0.31 -5.64 -0.21 1.36 
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3.3.4 DISCUSSION OF THE PRELIMINARY STUDY (LINEAR APPROACH) 
Strangely enough, ammonium, a typical product of post-mortem protein deamination, has rarely 
been considered as a potentially useful indicator of the time elapsed since death. This can probably 
be justified by the known variability of putrefaction phenomena occurring in corpses, which are 
responsible for most of the release of ammonium. Also, ammonium analysis in clinical chemistry is 
generally seen as a very problematic issue, with a large uncertainty caused by pre-analytical and 
analytical problems [51,61]. These considerations are presumably due to a general lack of interest 
for the determination of this analyte in forensic pathology as well. However, vitreous humour is 
typically sterile and is well protected from the environment by the sclera and the cornea, and 
therefore, less susceptible to putrefaction. Therefore, in the field of forensic pathology, it appears to 
be a suitable analyte for the evaluation of a time-dependent post-mortem increase in ammonium 
concentration. 
For this purpose, in order to avoid possible interferences originating from a non-standardised matrix 
such as a forensic sample, a separation method was preferred. On the grounds of previous research 
[10], CE was chosen as the most suitable analytical technique. Because of the lack of UV 
absorbance of the ammonium ion and in order to avoid the use of a conductivity detector, indirect 
detection using imidazole as the UV absorbing additive was adopted. Moreover, in order to improve 
the separation between ammonium and potassium peaks, 18-crown ether was added to the 
background electrolyte as a complexing agent, selectively retarding the mobility of the different 
cations. The validation parameters, according to the SWGTOX criteria, have been fully satisfied [54] 
even when performing minimal sample pre-treatment (limited to a 1:20 dilution). Because of the 
selectivity of indirect detection, extremely clean electropherograms were obtained even with injection 





Figure 5. Typical electropherograms of human vitreous humour (Top: NH4+ = 0.39; K+= 8.62; PMI= 
32 h; bottom: NH4+ = 1.18; K+= 20.81; PMI= 99 h) 
3.3.4.1 APPLICATION TO REAL CASES 
A preliminary study to investigate an expected correlation between ammonium concentration in the 
vitreous humour and PMI was conducted on 14 subjects whose time since death was well known on 
the basis of circumstantial information. The results are shown in Figure 6.  This shows that 




Figure 6. Correlation between PMI (hours) and vitreous NH4+ concentration (mM) determined in 14 
forensic deaths with known time since death. Equation y= (0.0132) x + (-0.012); r2 = 0.970, in which 
y = NH4+ concentration (mM); x = PMI (hours). 
Finally, as already reported by Tagliaro et al. [10], under the reported analytical conditions, other 
ions are also detectable, including sodium and potassium [23]. This opportunity may offer the 
possibility of grounding PMI evaluations onto two substantially independent parameters, such as 
ammonium and potassium, with a high expected increase in accuracy and reliability. This preliminary 
approach shows a new and simple application of CE. The next step is to fully validate the method 
with more cases. 
3.3.5 DISCUSSION OF THE LOGARITHMIC APPROACH 
As the number of samples increased (from 14 to 33), the correlation of the NH4+ concentration with 
the PMI was not as accurate as expected (Figure 7). Therefore, with a total of 33 forensic cases 
(Appendix I. 6.1.1 List of vitreous humour samples used for the study) a different statistical approach 
was explored. Since this approach was aimed at improving the correlation and the validation of the 
simultaneous determination of the two ions in post mortem cases, in a first step, calibration curves 
for ammonium and potassium were produced based on 33 medico-legal autopsies; the results are 
displayed in Figure 8 and Figure 9, respectively, showing a statistically significant relationship 
between both ions and PMI. The correlation is better described with polynomial equations as follows:  
Ammonium (NH4+): y = 2x10-6x2 + 0.0127x + 0.1461 
Potassium (K+): y = -0.0005x2 + 0.2018x + 6.173 
The correlation coefficient for vitreous humour ammonium vs. PMI is r2= 0.70 and that for potassium 







































Figure 7. Linear correlation of the concentration of ammonium against the PMI of 33 cases. 
Equation: y = 0.0131x + 0.1172, r2=0.67. 
 
Figure 8. Second degree polynomial correlation between PMI (hours) and vitreous NH4+ 
concentration (mM) determined in 33 forensic cases with known time of death. Equation                          









































































Figure 9. Correlation between PMI (hours) and vitreous K+ concentration (mM) determined in 33 
forensic cases with known time of death. Equation y= = -0.0005x2 + 0.2018x + 6.173; r2= 0.75 in 
which x = PMI (hours); and y = K+ concentration (mM). 
In a second step, an integrated use of these two parameters by using the average of potassium and 
ammonium concentrations was also tested, as shown in Figure 10. With the aim of balancing the 
weight of the two parameters in the calculation, the logarithm of the potassium concentration was 
used. This approach led to a small increase in the correlation coefficient (r2=0.74). 
 
Figure 10. Correlation between PMI (hours) and combined vitreous NH4+ and K+ concentrations 
(mM) determined in 33 forensic cases with known time of death. Equation y= -0.00001x2 + 0.0106x 
+ 0.4799; r2= 0.74 in which x = PMI (hours); and y = NH4+ and K+ concentrations combined. 
In order to calculate the experimental error during practical use of the method, each case was 
treated, one-by-one, as “unknown” and the theoretical PMI was calculated after having excluded its 


































































values, and the differences recorded (Table 5, Table 6, Table 7). The average absolute error of 
estimation for potassium and ammonium was 17.8 hours (SD = 15.3) and 20.2 hours (SD = 15.6), 
respectively.  
Table 5. Estimation of error for potassium. The coefficients of the curve are denoted by a,b,c,               


















1 15.28 77.1 -0.0006 0.2130 5.9396 51.3 -25.8 -0.34 -33.5 
2 14.03 47 -0.0005 0.2023 6.1764 43.5 -3.5 -0.08 -7.5 
3 12.30 21.5 -0.0005 0.2078 5.8904 33.6 12.1 0.56 56.1 
4 24.47 143 -0.0005 0.2030 6.1570 135.2 -7.8 -0.05 -5.4 
5 11.94 46 -0.0006 0.2044 6.2006 30.9 -15.1 -0.33 -32.9 
6 22.01 80.45 -0.0005 0.1904 6.4179 119.2 38.7 0.48 48.1 
7 4.67 17.45 -0.0005 0.1830 6.9891 -12.3 -29.7 -1.70 -170.3 
8 17.43 123.45 -0.0006 0.2093 5.9239 68.4 -55.1 -0.45 -44.6 
9 8.62 32 -0.0005 0.1986 6.4336 11.3 -20.7 -0.65 -64.6 
10 16.47 55 -0.0005 0.2000 6.1979 60.5 5.5 0.10 10.0 
11 14.95 43 -0.0005 0.2010 6.1465 50.0 7.0 0.16 16.4 
12 27.23 168.5 -0.0009 0.2412 5.3116 162.5 -6.0 -0.04 -3.6 
13 7.27 16.1 -0.0005 0.1930 6.5324 3.9 -12.2 -0.76 -76.0 
14 13.56 47.2 -0.0006 0.2029 6.1795 41.5 -5.7 -0.12 -12.2 
15 21.18 100.3 -0.0005 0.2008 6.1971 99.0 -1.3 -0.01 -1.3 
16 8.04 29 -0.0005 0.1967 6.4968 8.0 -21.0 -0.72 -72.4 
17 18.98 96.45 -0.0006 0.2072 6.0412 81.8 -14.6 -0.15 -15.1 
18 17.43 52.3 -0.0005 0.1978 6.1987 68.7 16.4 0.31 31.4 
19 23.66 99.45 -0.0005 0.1922 6.4117 142.8 43.3 0.44 43.6 
20 16.43 98.45 -0.0006 0.2165 5.8112 58.5 -39.9 -0.41 -40.5 
21 20.11 99.16 -0.0006 0.2041 6.1162 95.2 -3.9 -0.04 -4.0 
22 23.73 143.4 -0.0005 0.2016 6.1756 127.2 -16.2 -0.11 -11.3 
23 10.75 25 -0.0005 0.2015 6.1875 24.1 -0.9 -0.04 -3.7 
24 14.08 22.24 -0.0006 0.2120 5.6808 45.5 23.2 1.04 104.5 
25 10.66 23.35 -0.0005 0.2020 6.1643 23.6 0.3 0.01 1.1 
26 9.03 17.55 -0.0005 0.1998 6.2599 14.4 -3.2 -0.18 -18.1 
27 18.39 47.4 -0.0005 0.1968 6.1494 77.4 30.0 0.63 63.4 
28 15.86 47.4 -0.0005 0.2001 6.1652 56.4 9.0 0.19 19.0 
29 13.67 50.15 -0.0006 0.2037 6.1687 42.0 -8.1 -0.16 -16.2 
30 20.58 48.45 -0.0005 0.1935 6.1602 100.7 52.3 1.08 107.9 
31 5.74 6.55 -0.0005 0.1893 6.6474 -4.7 -11.3 -1.72 -172.3 
32 18.51 75.5 -0.0005 0.2010 6.1899 75.5 0.0 0.00 -0.1 




Table 6. Estimation of error for potassium. The coefficients of the curve are denoted by a,b,c,              



















1 0.99 77.1 -5.00E-07 0.0132 0.1356 65.2 -11.88 -0.15 -15.41 
2 1.01 47 5.00E-06 0.0123 0.1440 68.7 21.74 0.46 46.26 
3 0.51 21.5 1.00E-06 0.0129 0.1340 28.8 7.35 0.34 34.16 
4 1.36 143 2.00E-05 0.0115 0.1617 90.3 -52.71 -0.37 -36.86 
5 0.31 46 1.00E-06 0.0131 0.1510 12.1 -33.87 -0.74 -73.64 
6 1.49 80.45 9.00E-06 0.0115 0.1702 106.1 25.66 0.32 31.90 
7 0.31 17.45 4.00E-06 0.0124 0.1560 12.4 -5.08 -0.29 -29.11 
8 1.47 123.45 2.00E-06 0.0131 0.1330 100.2 -23.24 -0.19 -18.83 
9 0.39 32 3.00E-06 0.0125 0.1590 18.0 -13.99 -0.44 -43.73 
10 0.97 55 4.00E-06 0.0124 0.1487 64.7 9.74 0.18 17.72 
11 0.38 43 3.00E-07 0.0129 0.1537 17.6 -25.41 -0.59 -59.10 
12 2.29 168.5 1.00E-05 0.0117 0.1667 159.5 -9.01 -0.05 -5.35 
13 0.31 16.1 3.00E-06 0.0125 0.1535 12.5 -3.62 -0.22 -22.47 
14 0.60 47.2 1.00E-06 0.0129 0.1472 35.3 -11.87 -0.25 -25.15 
15 1.49 100.3 3.00E-06 0.0125 0.1502 104.2 3.89 0.04 3.88 
16 0.35 29 3.00E-06 0.0124 0.1614 15.2 -13.85 -0.48 -47.74 
17 1.38 96.45 2.00E-06 0.0127 0.1453 95.8 -0.67 -0.01 -0.70 
18 1.42 52.3 1.00E-05 0.0116 0.1532 100.5 48.20 0.92 92.16 
19 2.14 99.45 1.00E-05 0.0103 0.2057 162.2 62.79 0.63 63.14 
20 0.82 98.45 -8.00E-06 0.0147 0.0958 50.7 -47.79 -0.49 -48.54 
21 1.06 99.16 -4.00E-06 0.0139 0.1154 69.3 -29.82 -0.30 -30.07 
22 2.98 143.4 2.00E-05 0.0145 0.1207 161.3 17.90 0.12 12.49 
23 0.38 25 3.00E-06 0.0125 0.1559 17.9 -7.15 -0.29 -28.59 
24 0.31 22.24 4.00E-06 0.0123 0.1621 12.0 -10.26 -0.46 -46.14 
25 0.31 23.35 4.00E-06 0.0123 0.1630 11.9 -11.44 -0.49 -49.01 
26 0.31 17.55 4.00E-06 0.0124 0.1561 12.4 -5.19 -0.30 -29.56 
27 0.99 47.4 5.00E-06 0.0124 0.1447 66.4 18.99 0.40 40.07 
28 0.59 47.4 9.00E-07 0.0129 0.1472 34.2 -13.16 -0.28 -27.76 
29 0.56 50.15 1.00E-07 0.0130 0.1453 31.9 -18.26 -0.36 -36.41 
30 1.23 48.45 7.00E-06 0.0120 0.1451 86.1 37.64 0.78 77.68 
31 0.31 6.55 -6.00E-07 0.0133 0.1241 14.0 7.44 1.14 113.53 
32 0.91 75.5 -2.00E-06 0.0134 0.1315 58.6 -16.89 -0.22 -22.37 





Table 7. Estimation of error for the combined ammonium and potassium. The coefficients of the 




















1 1.09 77.1 -2.00E-06 0.0092 0.5089 64.0 -13.13 -0.17 -17.03 
2 1.08 47 8.00E-07 0.0087 0.5146 64.6 17.61 0.37 37.46 
3 0.80 21.5 -2.00E-06 0.0091 0.5038 32.6 11.11 0.52 51.69 
4 1.38 143 4.00E-06 0.0087 0.5152 94.8 -48.21 -0.34 -33.71 
5 0.69 46 -2.00E-06 0.0091 0.5200 19.1 -26.85 -0.58 -58.38 
6 1.42 80.45 3.00E-06 0.0082 0.5308 104.1 23.68 0.29 29.43 
7 0.49 17.45 3.00E-06 0.0082 0.5460 -6.9 -24.34 -1.39 -139.47 
8 1.35 123.45 -2.00E-06 0.0093 0.5017 93.5 -29.97 -0.24 -24.28 
9 0.66 32 2.00E-08 0.0087 0.5271 15.3 -16.70 -0.52 -52.18 
10 1.09 55 8.00E-07 0.0087 0.5180 65.6 10.64 0.19 19.35 
11 0.78 43 -1.00E-06 0.0089 0.5197 29.1 -13.92 -0.32 -32.37 
12 1.86 168.5 8.00E-06 0.0078 0.5390 147.3 -21.24 -0.13 -12.61 
13 0.59 16.1 1.00E-06 0.0086 0.5291 6.6 -9.52 -0.59 -59.10 
14 0.87 47.2 -1.00E-06 0.0089 0.5170 39.4 -7.80 -0.17 -16.52 
15 1.41 100.3 -3.00E-07 0.0088 0.5171 101.6 1.29 0.01 1.28 
16 0.63 68 -8.00E-05 0.0087 0.5146 15.1 -52.92 -0.78 -77.82 
17 1.33 96.45 -1.00E-06 0.0090 0.5190 90.9 -5.51 -0.06 -5.72 
18 1.33 52.3 3.00E-06 0.0083 0.5132 95.2 42.91 0.82 82.05 
19 1.76 99.45 6.00E-06 0.0076 0.5477 143.0 43.53 0.44 43.77 
20 1.02 98.45 -7.00E-06 0.0101 0.4849 54.8 -43.60 -0.44 -44.29 
21 1.18 99.16 -4.00E-06 0.0096 0.4985 73.4 -25.75 -0.26 -25.97 
22 2.18 143.4 -5.00E-06 0.0091 0.5170 205.7 62.35 0.43 43.48 
23 0.71 25 -1.00E-07 0.0088 0.5199 21.1 -3.88 -0.16 -15.52 
24 0.73 22.24 -6.00E-07 0.0089 0.5142 24.2 1.97 0.09 8.85 
25 0.67 23.35 2.00E-07 0.0087 0.5231 16.7 -6.61 -0.28 -28.31 
26 0.63 17.55 3.00E-07 0.0087 0.5227 12.7 -4.90 -0.28 -27.89 
27 1.13 47.4 1.00E-06 0.0086 0.5144 70.7 23.29 0.49 49.13 
28 0.90 47.4 -7.00E-07 0.0089 0.5167 42.7 -4.73 -0.10 -9.99 
29 0.85 50.15 -1.00E-06 0.0090 0.5163 37.0 -13.16 -0.26 -26.23 
30 1.27 48.45 2.00E-06 0.0084 0.5144 88.3 39.85 0.82 82.25 
31 0.53 6.55 9.00E-07 0.0086 0.5268 0.9 -5.66 -0.86 -86.41 
32 1.09 75.5 -2.00E-06 0.0092 0.5101 63.8 -11.72 -0.16 -15.53 
33 1.12 27.35 -3.00E-06 0.0095 0.4797 68.9 41.51 1.52 151.78 
 
When the concentrations of both ions were combined, the average absolute error was 21.5 hours 
(SD = 16.5). The average relative error, expressed as percentage of the PMI (%PMI), was 44%, 
42%, and 43% for potassium, ammonium and the combined concentration of both, respectively. It is 
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clear that the relative errors decrease steadily in increasing PMIs, from about 200% in the first hours 
down to low percentages for PMIs above 100 hours (Figure 11). 
This approach confirms the time-dependent increase of the concentration of potassium in vitreous 
humour, but more importantly, also shows that ammonium has a potential as a marker of the time 
elapsed since death, confirming the preliminary findings obtained with the linear correlation. 
 
Figure 11. Estimation error (expressed as %PMI) with the PMI (hours) for potassium, ammonium, 
and the sum of the concentrations of both ions. 
The comparative study of the correlation of the two parameters with the PMI and of the possibility of 
their use to infer the time of death in real forensic cases demonstrates the superiority of potassium 
in comparison with ammonium. However, ammonium can complement potassium for the estimation 
of PMI, particularly when potassium concentrations in the vitreous humour could have been affected 
by confounding factors, e.g. ocular traumas or drug overdoses [62] or the PMI is higher than 100 
hours [40]. In fact, because of the different mechanisms involved in the post-mortem increase of both 
ions, carrying out of their determination in parallel can provide mutual corroboration in terms of the 
reliability of the estimated PMI’s.  
With regard to the error related to the determination, the data show that as the PMI increases, so 
does the relative accuracy of its estimation, as depicted in Figure 11. This confirms previous findings 
reporting the variability of PMI estimation for PMIs below 26 hours [40].  
The main limitation of this approach is still the small number of the cases investigated, justified by 
obvious difficulties in the selection of traumatic or sudden deaths with known PMIs. A second 
limitation is related to the error of the determination. As it can be seen in Figure 11, at early PMIs 
(up to 60 hours) the error expressed as the % of the PMI is very high. However, as outlined in the 
introduction, for the determination of short PMIs, there are other methodologies based on the 
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3.3.5.1 APPLICATION TO REAL SAMPLES 
The logarithmic approach was applied to 11 unknown samples in which a PMI interval is known, and 
the results are shown in Table 8. The main limitation of this approach is the concentration limits. In 
the lower limit, PMIs smaller than 48 hours will not give high ion concentrations, and thus, cannot be 
taken into consideration for the statistical model. In the upper limit, concentrations higher than 3.87 
mM for NH4+ and combined use (ammonium and potassium) do not give a solution to the second-
degree equation, and so, the PMI cannot be estimated. This limitation is later addressed and solved 
with the ANNs. Overall, there is a potential usefulness of ammonium determination in the vitreous 
humour, in addition to potassium, as an objective biochemical parameter to infer the PMI.  
Table 8. Estimation of the PMI of 5 unknown vitreous samples. The coefficients of the curve are 
denoted by a,b,c, (y = ax2 + bx + c); c’ = [K+] – c. The estimated PMI is obtained as the solution to 
the quadratic equation using c’. NS stands for No Solution to the second-degree equation. Green 
indicates that they fall within the PMI interval, and yellow, that they fall very close. 
VH 
code 
[K+] (mM) a b c c' 
Estimated PMI 
(prediction ± 15.3) 
Real PMI 
(hours.min) 
3 12.82 -0.0005 0.2018 6.17 -6.65 51.5 48-72 
7 6.34 -0.0005 0.2018 6.17 -0.17 16.1 12.3 
8 15.91 -0.0005 0.2018 6.17 -9.74 71.4 80 
15 9.62 -0.0005 0.2018 6.17 -3.45 33.2 PMI≥ 21.20 
25 11.98 -0.0005 0.2018 6.17 -5.81 46.5 42-50 
30 11.66 -0.0005 0.2018 6.17 -5.49 44.6 24-48 
46 9.44 -0.0005 0.2018 6.17 -3.27 32.2 24-29 
51 9.76 -0.0005 0.2018 6.17 -3.59 34.0 PMI< 24 
65 8.96 -0.0005 0.2018 6.17 -2.79 29.6 PMI≥ 30 
67 19.65 -0.0005 0.2018 6.17 -13.48 99.8 71.20-73.20 




+] (mM) a b c c' 
Estimated PMI 
(prediction ± 15.6) 
Real PMI 
(hours.min) 
3 0.92 2.00E-06 0.0127 0.1461 -0.77 44.8 48-72 
7 0.00 2.00E-06 0.0127 0.1461 0.15 0 12.3 
8 2.67 2.00E-06 0.0127 0.1461 -2.53 177.4 80 
15 0.44 2.00E-06 0.0127 0.1461 -0.30 7.7 PMI≥ 21.20 
25 0.36 2.00E-06 0.0127 0.1461 -0.22 32.6 42-50 
30 6.71 2.00E-06 0.0127 0.1461 -6.56 464.7 24-48 
46 0.22 2.00E-06 0.0127 0.1461 -0.07 21.0 24-29 
51 0.29 2.00E-06 0.0127 0.1461 -0.15 27.1 PMI< 24 
65 1.04 2.00E-06 0.0127 0.1461 -0.90 54.4 PMI≥ 30 
67 1.27 2.00E-06 0.0127 0.1461 -1.13 71.9 71.20-73.20 
        








log[K+]   
(mM) 
a b c c' 
Estimated PMI 
(prediction ± 16.5) 
Real PMI 
(hours.min) 
3 2.03 -1.00E-05 0.0106 0.4799 -1.55 158.4 48-72 
7 0.80 -1.00E-05 0.0106 0.4799 -0.32 14.8 12.3 
8 3.87 -1.00E-05 0.0106 0.4799 -3.39 NS 80 
15 1.43 -1.00E-05 0.0106 0.4799 -0.95 81.9 PMI≥ 21.20 
25 1.44 -1.00E-05 0.0106 0.4799 -0.96 83.6 42-50 
30 7.77 -1.00E-05 0.0106 0.4799 -7.29 NS 24-48 
46 1.19 -1.00E-05 0.0106 0.4799 -0.71 55.3 24-29 
51 1.28 -1.00E-05 0.0106 0.4799 -0.80 65.5 PMI< 24 
65 2.00 -1.00E-05 0.0106 0.4799 -1.52 154.1 PMI≥ 30 
67 2.57 -1.00E-05 0.0106 0.4799 -2.09 244.7 71.20-73.20 
 
3.3.6 DISCUSSION OF THE NEURAL NETWORKS APPROACH 
As mentioned in the introduction (2.1 Artificial Neural Networks (ANNs)), ANNs are a great 
multivariate analysis tool since it generalises, and therefore, it is not necessary to know the 
connection between input and output data and it deals well with measurement errors. Given all these 
advantages and the fact that the correlation and prediction of the previous regressions could be 
improved, in addition to the fact that lower PMIs could be used, this approach was explored. 
Input data considered ammonium and potassium concentrations and the sodium ratio (peak area of 
sodium/peak area IS), (total of three inputs); and PMI was the output. The accuracy of the training 
and test (r2 score) was the main metric used for the evaluation of the network. If accuracies were 
similar, the mean absolute error (MAE) was used as well. The r2 score was expected to be as close 
to 1 as possible, whereas the MAE must be as low as possible, expecting a higher error in the test 
set than in the training set (because the test set has less samples). The networks were built based 
on the different solvers for the weight optimisation: Adam, SGC, and LBFGS. For each solver, the 
different parameters were optimised and once the final network was tuned and validated, 11 
untrained samples (not used in the learning process of the network) were used to test it. 
Firstly, the train/test split must be decided, that is, to decide how many samples are used for training 
and how many for testing. Ideally, the samples in the training split should cover the entire domain of 
the problem, i.e. a wide selection of different PMIs. Hence the more samples in the training set, the 
better trained the network is. However, enough samples should be left to test the network [22]. A 
good compromise is a 75/25 split, 75% of samples are used for training and 25% for testing. With a 
total of 38 available samples (Appendix I. 6.1.1 List of vitreous humour samples used for the study), 
28 were used for training, and 10 for testing. Secondly, the data should be normalised, which was 
done through the MinMaxScaler of scikit-learn (Appendix I. 6.1.2 Train test split and data pre-
processing). Thirdly, the evaluation of the network with different solvers was carried out. 
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3.3.6.1 ADAM SOLVER 
3.3.6.1.1 Network training 
The code for the Adam solver can be found in Appendix I (6.1.3 Code for Adam solver). Several 
parameters were optimised. Table 9 summarises the optimisation results of different network 
parameters. The number of hidden layers was set to 1 because according to literature [24] more 
hidden layers are for larger and more complicated datasets. The first parameter to optimise was the 
number of nodes. For this parameter, the accuracy and the MAE must be taken into account [23]. 
The ideal number of nodes in the hidden layer is when the MAE is kept to the minimum value without 
losing accuracy. As seen in Figure 12, four nodes yielded the best accuracy and lowest error. 
Table 9. Parameter optimisation summary with the Adam solver. The names in cursive indicate the 
part of the code belonging to that parameter. The option highlighted in grey indicates the best value 
for the corresponding parameter. 
 
 
Number of nodes in hidden layer (hidden_layer_sizes) 
Accuracy of 
prediction (r2) 
1 2 3 4 5 6 7 8 8 10 
Training set 0 0 0 0.86 0.85 0.86 0.86 0.86 0.86 0.86 
MAE Training 32.1 32.1 32.1 11.4 11.5 11.5 11.4 11.4 11.4 11.4 
Test set 0 0 0 0.701 0.69 0.69 0.69 0.69 0.69 0.69 
MAE Test 45.7 45.7 45.7 21.7 21.8 21.8 22.1 22.1 22.1 22.1 




identity logistic tanh relu 
Training set 0.75 0.86 0.88 0.78 
Test set 0.82 0.70 0.67 0.80 
Regularisation factor (α) (alpha) 
Accuracy of 
prediction (r2) 
0.10 0.01 0.001 0.2 0.3 
Training set 0.86 0.87 0.88 0.85 0.00 
Test set 0.70 0.68 0.67 0.71 0.01 
Learning rate (learning_rate_init) 
Accuracy of 
prediction (r2) 
0.0001 0.001 0.01 0.10 0.20 0.30 0.40 0.50 0.60 0.70 
Training set 0.00 0.86 0.86 0.82 0.00 0.00 0.00 0.00 0.00 0.00 
Test set 0.00 0.70 0.70 0.71 0.00 0.00 0.00 0.00 0.00 0.00 
Random seed in MLP regressor (random_state) 
Accuracy of 
prediction (r2) 
0 17 25 28 88 99 
Training set 0.86 0.86 0.86 0.86 0.86 0.86 




Figure 12. Number of nodes in the hidden layer against MAE for Adam solver 
The next parameter was the activation function, where the best option was the logistic activation 
function. The network was also tested with the identity activation function, but it yielded the worst 
accuracies towards the end. The regularisation factor and learning rate were optimised and the ones 
with higher accuracy in both tests were selected. Finally, the random state in the MLPRegressor was 
explored. Random seed randomly generates the weights, initialises the bias and shuffles the data in 
the Train/Test split. Effectively, different models can be obtained when using the exact parameters 
but different random seeds. This factor is highly important with smaller datasets, since if a model is 
robust, changing the random state should not greatly affect accuracy [24]. Six random numbers were 
tested and as seen from Table 9, the accuracy is still high for all case scenarios. Hence, the network 
is robust. The accuracy graphs and the error as a function of the PMI are shown in Figure 13. Much 
like with the logarithmic approach, the error (expressed as %PMI) is high at low PMIs and decreases 











































































Figure 13. Training and test graphs for the final network (r2training = 0.86 and r2test = 0.70). Estimation 
error (expressed as %PMI) with the PMI (hours) for the training and test samples. 
3.3.6.1.2 Validation 
Finally, the model was validated with two different methods (Code can be found in Appendix I. 6.1.3.6 
Validation). Validation is needed to see whether the network is over or under fitted, whether it 
generalises well, and to evaluate the model’s performance on untrained data. The first validation 
was performed through k-fold cross-validation. It is the most common method for validating neural 
networks. K stands for the number of folds or “divisions” of all data (training and testing). If k is 5, the 
data is divided in five folds, where four folds are used for training and one for testing; this allows for 
a different selection of random states in the Train/Test split. This process is repeated until all 5 folds 
have been used as testing. For each run, the accuracy of the network is measured with the r2 
parameter. For models that are not computationally costly, three to five different cross validation runs 
are recommended [63]. However, NNs are computationally costly, so only one run is performed. The 
value of k is selected to be 5, as recommended for moderately sized datasets.  
Table 10. Summary of the 5-fold validation process. 
Cross-validation score (5-fold) 
 Fold 1 Fold 2 Fold 3 Fold 4 Fold 5 Mean STD 
Accuracy of the 
network (r2) 
0.76 0.72 0.90 0.88 0.83 0.82 0.08 
A second validation was performed using the leave-one-out (LOO) method, using the MAE as the 
accuracy metric. LOO is used to test the model’s performance on untrained samples. It is a form of 
cross-validation where k equals the number of samples, which is this case is 38. For each fold (or 
run) it takes one sample out (used for testing), whereas the remaining 37 are used for training. 
Usually, this method is extremely computationally expensive, and it is not used in NNs unless a 
supercomputer can be used [64]. However, since the present network is smaller than usual, the LOO 
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very good in all five folds. In addition, the MAE is 18.5, which agrees with the optimisation process 
results where MAE is between 11 and 21 (Table 9). 
3.3.6.2 SGD SOLVER 
3.3.6.2.1 Network training 
The code for the SGD solver can be found in Appendix I. (6.1.4 Code for SGD solver). The results 
of the optimisation of parameters are found in Table 11. 
Based on Figure 14, two nodes were selected. The regularisation factor was chosen to be 0.01 even 
when the accuracy was very similar to 0.001 because a higher alpha means a simpler model. If the 
problem is not too complex, choosing a lower alpha might compromise generalisation [24]. 
Regarding momentum, values between 0.1-0.8 have similar accuracies. Since the momentum is the 
parameter that helps to break from the local minima, a high value increases the chances of missing 
the solution whereas a lower value might not be enough to break from the local minima [22]. As a 
compromise, 0.3 was chosen. Nesterov momentum is a different type of momentum, which 
guarantees a better convergence rate [65]. The two options were whether to activate (True) or 
deactivate (False); accuracy was better without the Nesterov momentum. 
 
Figure 14. Number of nodes in the hidden layer against MAE for SGD solver 
As seen in Table 11, the network looks promising, with accuracies similar to the one with the Adam 
solver. Therefore, it was validated similarly. The mean 5-fold cross-validation accuracy was -0.29, 

































Table 11. Parameter optimisation summary with the SGD solver. The names in cursive indicate the 
part of the code belonging to that parameter. The option highlighted in grey indicates the best value 
for the corresponding parameter. 
Number of nodes in hidden layer (hidden_layer_sizes) 
Accuracy of 
prediction (r2) 
1 2 3 4 5 6 7 8 8 10 
Training set 0.63 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MAE Training 19.2 13.8 32.3 32.3 32.3 32.3 32.3 32.3 32.3 32.3 
Test set 0.65 0.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MAE Test 28.1 23.1 45.7 45.7 45.7 45.7 45.7 45.7 45.7 45.7 
Activation function for the hidden layer (activation) 
Accuracy of 
prediction (r2) 
identity logistic tanh relu 
Training set 0.75 0.80 0.59 0.73 
Test set 0.82 0.71 0.68 0.76 
Regularisation factor (α) (alpha) 
Accuracy of 
prediction (r2) 
0.10 0.01 0.001 0.2 0.3 
Training set 0.75 0.75 0.75 0.75 0.75 
Test set 0.82 0.82 0.82 0.82 0.82 
Learning rate (learning_rate_init) 
Accuracy of 
prediction (r2) 
0.0001 0.001 0.01 0.1 0.2 0.3 0.4 0.5 0.6 0.7 
Training set 0.71 0.73 0.50 0.09 0 0 0 0 0 0 




0.01 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
Training set 0.81 0.81 0.81 0.82 0.82 0.82 0.82 0.82 0.82 0.82 





Training set 0.82 0.79 
Test set 0.71 0.74 
Random seed in MLP regressor (random_state) 
Accuracy of 
prediction (r2) 
0 17 25 28 88 99 
Training set 0.82 0.82 0.82 0.82 0.82 0.82 




3.3.6.3 LBFGS SOLVER 
3.3.6.3.1 Network training 
The code for the LBFGS solver can be found in Appendix I. (6.1.5 Code for LBFGS). The results of 
the optimisation of parameters are found in Table 12. As seen in Figure 15, the optimal number of 
nodes was three. The activation function and the regularisation factor were identity and 0.001, 
respectively.  
Table 12. Parameter optimisation summary with the LBFGS solver. The names in cursive indicate 
the part of the code belonging to that parameter. The option highlighted in grey indicates the best 
value for the corresponding parameter. 
Number of nodes in hidden layer (hidden_layer_sizes) 
Accuracy of 
prediction (r2) 
1 2 3 4 5 6 7 8 9 10 
Training set 0.79 0.82 0.81 0.00 0.00 0.86 0.86 0.86 0.90 0.86 
MAE Training 13.6 12.1 12.7 32.2 32.2 11.4 11.4 11.4 10.6 11.4 
Test set 0.71 0.70 0.75 0.00 0.00 0.69 0.69 0.69 0.72 0.69 
MAE Test 23.2 22.2 20.4 45.7 45.7 22.0 22.0 22.0 21.2 22.0 




Identity Logistic tanh relu 
Training set 0.75 0.81 0.49 0.78 
Test set 0.82 0.75 0.40 0.80 
Regularisation factor (α) (alpha) 
Accuracy of 
prediction (r2) 
0.1 0.01 0.001 0.2 0.3 
Training set 0.81 0.83 0.88 0.82 0.82 
Test set 0.75 0.36 0.66 0.71 0.72 
Random seed in MLP regressor (random_state) 
Accuracy of 
prediction (r2) 
0 17 25 28 88 99 
Training set 0.81 0.79 0.79 0.82 0.79 0.82 
Test set 0.75 0.71 0.71 0.40 0.71 0.40 
As shown in Table 12, the change in random seed did not achieve very good results. Random seed 
28 and 99 had very low accuracies for the test set. In other words, the network does not generalise 
well, i.e., it is not robust enough. For that reason, this network was not further validated nor used for 




Figure 15. Number of nodes in the hidden layer against MAE for LBFGS solver 
3.3.6.4 APPLICATION TO REAL UNKNOWN SAMPLES 
Due to the low number of samples, only 11 untrained samples were left to validate the model (Code 
in Appendix I. 6.1.6) where some information about the PMI or its range was available. The 
predictions are summarised in Table 13. For the predictions, the Adam-solver-tuned network with 
seven different Train/Test splits was used. As seen from Table 13, the predictions are generally good 
except for samples 51 and 67. The incorrect predictions of these two samples might be due to the 
data set not covering a wider and more comprehensive PMI range. 
Table 13. Prediction of PMI for real unknown samples. The prediction results are given taking into 
account the standard deviation (the values rom column labelled as SD (n=7). Green indicates that 
they fall within the PMI range, and yellow that they fall close. 
Real unknown samples (untrained) 
VH sample PMI predicted with NN SD (n=7) Real PMI (hrs.min) 
3 51 7 48-72 
7 13 4 12.30 
8 71 9 80 
15 22.3 5 PMI≥ 21.20 
25 56 19 42-50 
30 31 19 24-48 
33 40 11 32 
46 29 4 24-29 
51 27 15 PMI< 24 
65 31 5 PMI≥ 30 



































Hence, the main limitation of this study is the size of the dataset. In ANNs, the size of the data set is 
directly related to the capacity of the network to learn and generalise. In addition, the dataset should 
cover the widest possible range of PMIs [22]. In the present study, a total of 38 samples with known 
cause of death and PMI (7–168h) were used. In comparison, a study carried out by Bocaz-Beneventi 
et al.[23], with the same purpose but a total number of 72 samples and a slightly different network, 
achieved more accurate estimations. This extra 34 samples increased the accuracy of the network, 
and thus, the accuracy of predictions.  
3.3.7 DISCUSSION OF THE THREE APPROACHES 
With the linear and logarithmic approach, samples with small PMIs (lower than 48h) can skew the 
correlation. Hence, more accurate methods for estimating the time of death at lower intervals are 
used in these cases. Thus, these cases are usually not taken into account. However, with ANNs, all 
PMIs are valid. Since networks learn by iterative analysis, they are unbiased by small PMIs. In 
comparison with the logarithmic and linear approaches, ANNs are superior.  
Table 14. Summary of predictions of untrained samples with all three statistical approaches. Values 
highlighted in blue indicate the most accurate predictions for each sample. NS stands for No Solution 



























0.0 -27.1 6.34 7.4 16.1 14.8 13 
8 80 2.67 203.3 177.4 15.91 51.9 71.4 NS 71.4 
15 PMI≥ 21.20 0.44 34.4 7.7 9.62 22.6 33.2 81.9 22.3 
25 42-50 0.36 28.4 32.6 11.98 33.6 46.5 83.6 56.0 
30 24-48 6.71 509.0 464.7 11.66 32.1 44.6 NS 31.0 
46 24-29 0.22 17.2 21.0 9.44 21.8 32.2 55.3 29.0 
51 PMI< 24 0.29 23.1 27.1 9.76 23.3 34.0 65.5 27.0 




1.27 97.4 71.9 19.65 69.3 99.8 244.7 120.0 
Table 14 gathers the predictions of the three different approaches: linear, logarithmic and NN. For 
example, in VH 7, which has a small PMI, the best prediction was with the ANN. This proves that the 
network has learned small PMIs, and thus, there is no need to eliminate them. The incorrectly 
predicted samples VH 51 and 67 is due to the lack of additional samples with similar input data 
values, hindering the network from learning the different variations in combinations of potassium and 
ammonium concentrations and sodium ratio. The main limitation of the linear and polynomial models 
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is the removal of small PMIs. In addition, in the polynomial model, concentrations higher than 3.87 
for NH4+ and combined use do not give a solution to the second-degree equation, so there is no 
estimated PMI. Regarding neural networks, their main limitation is the size of the data set. The more 
data available, the more information the network can learn allowing it to make more accurate 
predictions.  
3.3.8 AMMONIUM CONCENTRATION DIFFERENCES IN THE TWO EYES 
Another aim of the project was aimed at verifying the consistency of ion concentrations between the 
two eyes. A similar study was carried out by Tagliaro et al.[48] on potassium concentrations and 
reported no significant difference. 
The statistical difference between the ammonium concentrations in the two eyes of the same subject 
was evaluated in 20 forensic autopsies. The mean concentrations of NH4+ ranged from 0.07 to 6.45 
mM with PMI’s varying from 31 up to 89 h. The differences in concentration between the two eyes 
were evaluated using a paired student’s t-test (α = 0.01). The findings suggest that no statistically 
significant differences exist (p value for two tails = 0.87). In addition, a good correlation was found 
between the two eyes, expressed by r2= 0.94. 
The present data show that there is also no substantial difference in the concentrations of ammonium 
between the two eyes. This evidence supports the hypothesis that there is an even progression of 
ammonium ion production in this body compartment.  
3.4 CONCLUSIONS 
In summary, the present method represents a new, simple application of CE in the forensic 
environment, where separation methods are precious for dealing with the complexity and variability 
of post-mortem biological matrices. An increase in ammonium concentration was observed up to 
168 hours after death, thus offering a new analytical tool for PMI evaluation that is useful for a much 
wider time span than that offered by potassium analysis (limited to about 90–100 hrs). After acquiring 
more real vitreous samples and further validating the method, ammonium analysis can become, “per 
se” or in combination with potassium, a powerful tool for unravelling one of the most challenging 
issues of forensic investigation, such as the accurate determination of the time of death. 
In conclusion, the findings support the potential usefulness of ammonium determination in vitreous 
humour, in addition to potassium, as an objective biochemical parameter for inferring the PMI, when 
combined with ANN multivariate statistical analysis. In addition, the present work shows the 
suitability of capillary electrophoresis for performing rapid simultaneous determinations.  
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3.5 FUTURE RESEARCH 
Future research should therefore concentrate on the acquisition of more vitreous humour samples 
with a wide range of different PMIs and further analysis to build a more reliable neural network that 




LIQUID CHROMATOGRAPHY (LC) APPLIED TO FORENSIC SCIENCE 
1. LIQUID CHROMATOGRAPHY COUPLED WITH MASS SPECTROMETRY 
1.1 LIQUID CHROMATOGRAPHY (LC) 
Liquid chromatography (LC) is a widely used technique due to its accuracy, sensitivity, adaptability, 
possibility of automation, suitability for the separation of thermally fragile or non-volatile species, and 
its extensive applicability in industry and science. It allows for separating the components of a 
mixture on the bases of their distribution between a mobile phase, which is usually a solvent or a 
buffer, and a stationary phase containing small, packed particles. The differences type of interaction 
of the analytes with the two phases determines their separation [66]. 
A liquid chromatograph is constituted of four main parts: an inlet system, a high-pressure pump, a 
separation compartment and a detector. The inlet system allows the efficient introduction of the 
sample with minimal sample loss. Once the sample is introduced, it goes to the separation 
compartment where the column is located. Then, the samples are separated and go to the detector. 
Depending on which property of the analyte to focus on and the required sensitivity, there is a great 
variety of commercial detectors such as Ultraviolet-visible absorption (UV-Vis), also in the diode 
array (DAD) configuration, electrochemical, fluorescence, conductivity, Fourier transform infrared 
(FRTIR), and mass spectrometry (MS) [67,68]. According to the principle of separation, LC has 
different modes, such as normal phase, reverse phase, ion exchange, size exclusion, bio-affinity, 
and chirality [66]. The focus here will be on reverse phase separations. 
1.1.1 REVERSE PHASE CHROMATOGRAPHY 
Chromatographic separations take place in a chromatographic column. Columns are made of 
stainless steel with alumina or silica gel as a substrate and the stationary phase. In reverse phase, 
columns are packed with silica gel particles with their surfaces covered by alkyl groups bound to 
silanol (Si-OH) groups. Long alkyl chains (C18) bind stronger to low polarity organic molecules, 
whereas highly polar analytes pass through. Shorter alkyl columns (C8) have lower retention for low 
polarity analytes [69]. Nowadays, the ability to produce highly spherical, pure, and homogeneous 
silica particles has increased the reproducibility and resolution of analysis; and the high coverage of 
the stationary phase has led to improved retention times. The speed and efficiency of separation 
has improved in the past years, as well as their suitability for a greater range of analytical samples, 
due to the use of new stationary phases [68]. Usually, a guard (or pre-column) is placed before the 
analytical column in order to extend the life of the analytical column by protecting it from 
contaminants from the solvents and/or sample components that bind irreversibly to the stationary 
phase. Regarding the liquid phase, they have to be aqueous mixtures with methanol, acetonitrile, 
and additives as buffers [66].   
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1.1.2 ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY (UPLC) 
A column’s separation power increases with decreasing particle size which is unfortunately bound 
to a high pressure increase to allow enough flow rate. So far, a compromise was reached with a 
particle size of 5 µm. With the intention of shortening analysis time and increasing resolution, the 
column particle size was decreased below 2 µm, thus developing a new technique called Ultra 
Performance Liquid Chromatography (UPLC) or fast chromatography [70]. For flows of 0.5-1.0 
mL/min, the pressure can reach up to 1200 bar. Due to the fast analysis in UPLC, the detectors need 
to have a sufficiently high sampling rate to obtain enough data points for reproducible results. There 
are currently only three detectors in the market that meet the condition: DAD, UV/VIS, and MS [68]. 
1.2 MASS SPECTROMETRY (MS) 
The basic principle of mass spectrometry is the generation of ions, separation of these ions based 
on their mass-to-charge ratio (m/z), and detection based on their respective m/z abundance. A mass 
spectrometer consists of three parts: the ionization source, which generates the ions by electric field 
and thermally by impacting energetic electrons, ions, and neutral atoms of photons; the mass 
analyser which separates the ions by magnetic, electric, or field-free regions; and the detector [69]. 
The analyser must be kept under vacuum to allow a free path for the ions. A low vacuum has a 
positive effect in mass resolution (ability to separate close ions) and sensitivity [71]. 
1.2.1 LC–MS ION SOURCES 
Since LC is unable to provide unequivocal identification of different analytes in a mixture based only 
on retention times, coupling it with MS can really help the identification of species as they elute from 
the column. The mass spectrometer combines high selectivity with a universal detector. In addition, 
the obtained mass spectra are unequivocal proof of the identification of the unknown substance. 
Also, it increases the sensitivity of the analysis and reduces analysis time [66,72]. 
There is a wide variety of sources depending on the substances of interest. Examples of said sources 
are electrospray ionisation (ESI), atmospheric pressure photoionisation (APPI), and atmospheric 
pressure chemical photoionisation (APCI) are the most popular [69]. The focus of this thesis is 
directed towards ESI, IonBoosterTM (iB), and APCI. 
1.2.1.1 ESI, IB AND APCI  
ESI is a soft ionisation technique that takes place at atmospheric pressure. It transforms the ions 
from solution into the gas phase through the nebulisation of the liquid into highly charged aerosol 
droplets, dissolution of the charged droplets, and ionisation of the analyte. This process takes place 
by applying an electrical potential to a liquid in an electrospray needle (Figure 16). For ESI to work, 
the solvent containing the analyte needs to be volatile. As mentioned above, it starts the ionisation 
at atmospheric pressure, slowly reaching the high vacuum necessary for the mass analyser. With 
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this source, the analytes are ionised in solution. Generally, the best sensitivity is achieved using low 
flow rates. ESI is superior to APCI due to its broad range of analyte tolerance in terms of mass and 
polarity (Figure 17) [67,69]. 
ESI APCI 
  
Figure 16. Fundamental principles of ESI and APCI sources. The green arrows indicate how the 
heated drying gas moves inside the source. The small red spheres represent the sample. The black 
arrows indicate the part of the source named. The sample enters through the sample inlet, the 
analytes are ionised and go to the mass analyser through the glass capillary. Adapted from [73,74]. 
The iB was developed by Bruker Daltonics and can be defined as a high-temperature ESI source. It 
is heated in the spray zone and results in a highly efficient desolvation process when using flow rates 
higher than 200 µL/min. For this source, a sheath gas (nitrogen) must be used to prevent the thermal 
degradation of the analytes prior to the electrospray process. By increasing the ionisation efficiency, 
it lowers detection limits and enhances sensitivity. In comparison with ESI, it offers greater sensitivity 
under high flow rates [73,75]. 
APCI is also a soft ionisation technique where the analyte solution is nebulised by means of a 
pneumatic nebuliser. The aerosol is then vaporised in a heater chamber and analytes are ionised by 
solvent ions created in a corona discharge. Lastly, they go to the high vacuum of the mass analyser 
through a system of nozzles and skimmers and a drying gas (Figure 16). With this source, the 
analytes are ionised in the gas phase. In terms of technical conditions, APCI can be used with small 
amounts of non-volatile and volatile buffers and flow rates no higher than 2 mL/min. As a prerequisite, 
analytes should be thermally stable. APCI does not have the same potential as ESI but it allows the 




Figure 17. Comparison between ESI and APCI [69]. 
1.2.2 MASS ANALYSER 
A mass analyser separates the ions according to their m/z ratio. It can operate in two modes: Scan 
mode (SCAN), which monitors all the m/zs in the sample and Selected Ion Monitoring (SIM) which 
monitors a targeted ion. It operates under vacuum (as the detector) in order to allow the analyte ions 
to travel from one side to the other without being hindered by air molecules. Different types of mass 
analysers can be used depending on the accuracy and/or sensitivity desired. They are summarised 
in Table 15. High Resolution MS is able to separate ions that differ in mass by 0.0001 atomic mass 
units (amu), whereas low resolution ones are able to separate them when they differ by at least 1 
amu. In Multiple stage MS, both molecular and fragment ions are produced and detected; whereas 
in single step MS, only molecular ions are produced and detected [69,72]. 
Table 15. Different types of mass analysers. Adapted from [76]. 
Criterion   Mass analyser 
Low resolution MS Single step MS Quadrupole (Q) 
  Ion trap (IT) 
Low resolution MS Multiple step MS Triple quadrupole (QQQ) (MS/MS) 
  Ion trap (MSn) 
  Quadrupole Ion Trap (QTRAP) (MSn) 
High resolution MS Single step MS Time of flight (TOF) 
High resolution MS Multiple step MS Quadrupole TOF (QTOF) 
A quadruple (Q) is made of four parallel rode electrodes, with each pair of opposite rods held at the 
same potential composed of AC (alternating current) and DC (direct current). A resonant frequency 
is created for each m/z and only ions of a specific m/z pass through the quadrupole, whereas others 
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are discarded. If the resonant frequency is changed, a full mass range can be scanned. The 
quadrupole can be used in SIM mode: selection of a number of masses (high selectivity); or SCAN 
mode: an ion is only detected a fraction of the total scan, and the masses reach the detector 
sequentially (low sensitivity) [69]. 
An Ion Trap (IT) is made by two hyperbolic electrodes and a ring electrode. Radio frequency (RF) 
and DC potentials are applied between them. The ions are introduced and accumulated in the centre 
of the IT and then sequentially ejected to the detector due to the application of RF (mass SCAN). 
Only ions of a certain m/z will be ejected to the detector (those with stable trajectories), whereas 
unwanted ions will collide with the walls and will be discarded due to their unstable trajectories [69]. 
An MS/MS combination can also be achieved with an IonTrap (MSn) when a single ion trap serves 
as both the mass analyser and collision cell. Ions are accumulated, the precursor ion is isolated and 
specifically activated by using a specific fragmentation amplitude, and product ions are created. Then 
the fragments (product ions) are focused, ejected, and detected (Figure 18). A very interesting 
feature of this instrumentation is that only precursor ions are selected and excited in comparison with 
QTOF, where both precursor and fragment ions are selected and excited [74].   
 
Figure 18. Fundamentals of IonTrap in MSn mode [74]. 
It is possible to use to mass analysers in tandem (MS/MS) to create new operational possibilities 
where both of them can be used in SCAN or SIM mode. This is the case of the triple quadrupole 
configuration (QQQ) where the first (Q1) and last (Q3) quadrupole can scan masses sequentially or 
do SIM; while the second quadrupole (Q2), the one in the middle, acts as a “collision cell” where 
mass fragmentation occurs. It does not filter the ions, but rather accepts the ones coming from Q1 
and passes all ions formed by collision to Q3 [69,72].  
The QTRAP instrument is in the QQQ geometry, but one quadrupole can also trap and store ions. 
Here, Q3 is the hybrid quadrupole denoted as Linear Ion Trap (LIT), which means it can function as 
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one or the other. It offers the properties of QQQ, and in addition, the ones from the LIT, such as 
combinations of ion accumulation and scanning (enhanced sensitivity) and higher order tandem MS 
[69].  
The principles of the time of flight (TOF) analyser relies on the acceleration of the ions in an electric 
field until they reach the detector through a free vacuum path of known length. Speed is inversely 
proportional to the mass of the ion, so lighter ions will reach the detector earlier. It is key that the 
ions of all m/z coming from the source are transferred, simultaneously and instantaneously, into the 
mass analyser by means of a pulsed ion beam or by pulsing ion packages out of a continuous source. 
Since they offer high ion transmission, TOF analysers are highly sensitive [69]. 
The QTOF instrument is also in the QQQ geometry, but one quadrupole is replaced by an orthogonal 
TOF. Q1 is a mass analyser where the precursor ion of interest is selected, Q2 is the collision cell 
where the precursor ion undergoes fragmentation, and Q3 is a TOF analyser. As mentioned before, 
it is key that the ions are transferred, simultaneously and instantaneously, into the mass analyser. 
Therefore, after exiting the collision cell, the ions are focused into a parallel beam that enters the 
TOF. Hence, QTOF is very sensitive to the quality of the incoming ion beam. QTOF offers high mass 
resolution measurements, identification power, ability to record all ions in parallel without scanning, 
and increased selectivity which are important in forensic toxicology [72,77] 
1.2.3 DETECTOR 
The mass detector is crucial in the instrument. After the analytes are separated in the mass analyser 
based on the m/z, the detectors receive the current signal generated from the incident ions which is 
a reflection of the absolute or relative concentration of the analyte. It amplifies and registers the 
signal. A good detector is defined on the basis of low noise and cost, high collection efficiency and 
amplification, fast response time, reproducibility, long life, and long-term stability. Examples of some 
commercial detectors are high mass detection detectors, channel electron multipliers, Faraday cups, 
electron multipliers, scintillation counters, photographic plates, resistive anode encoder image 
detectors, conversion dynodes, helium leak detectors, and cryogenic detectors [78]. 
1.3 FORENSIC APPLICATIONS 
In forensic toxicology, LC-MS/MS has gained momentum in the field of drug screening and 
quantification. The main advantage is that the use of reference standards (sometimes expensive or 
hard to acquire) is not needed since accurate molecular weight information can be obtained with 
techniques such as high-resolution mass spectrometry (HRMS). This allows the unequivocal and 
robust determination of unknown substances present in different biological matrices (blood, urine, 
serum, hair, and vitreous humour). In order to reliably use tandem MS in a forensic field, a thorough 
assessment of ion suppression and interferences must be performed. The correct selection of the 
ions to be monitored must be appropriate and the mass spectrometer must be optimised for each 
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analyte. For the unequivocal identification of compounds, two or more ion transitions must be 
selected. Since it is vital to obtain structural information, the TOF is an optimal choice for such task, 
as well as for the identification of unknown substances in any of the biological matrices mentioned 
above [79]. In this field, LC-MS/MS has been used for the determination of drugs of abuse (DoA) 
and novel psychoactive substances (NPS) such as lysergic acid diethylamide, (LSD), cocaine and 
its metabolites, opiates, amphetamines, cannabinoids, synthetic cannabinoids, phenylcyclohexyl 
piperidine (PCP), and g-hydroxybutyrate (GHB) in biological samples [72]. LC-MS has also been 
applied to the determination of illicit drugs and its metabolites on serum samples of subjects driving 
under the influence (DUI) [80].  
LC-MS has also been used as a predictive tool for raw materials information in home-made synthesis 
of nitrate ester explosive erythritol tetranitrate (ETN) [81] and as a tool for the detection of explosives 
and quantification among different types of explosives [82]. Also, LC-MS has been used to test the 
prevalence of GSR in police cars [83]. Wastewater epidemiology is a discipline of forensic science 
which estimates drug consumption in an area or community through the analysis of drugs and its 
metabolites in wastewater, where LC-MS/MS is the technique of choice. For instance, in the study 
by Centazzo et al., [84], they analysed wastewater in different areas of New York with LC-QQQ, 
finding amphetamines, cocaine, opioids, and cannabis. In the field of trace chemicals analysis, such 
as chemical warfare agents, LC-MS is a very useful technique for the determination of the 
metabolites of sarin, sulphur mustard, and ethyl methylphosphonothioate in urine [85]. 
Finally, another important application of LC-MS(MS) is the elucidation of the metabolic pathways of 
NPS. NPS are chemical analogues or derivatives of classic illicit substances designed to produce 
effects similar to that of the illegal drugs they imitate [86]. Several metabolic pathways have recently 
been elucidated, such as 5F-AKB-48 [87], THJ-018 and THJ-2201 [87], FUBIMINA [87], and APINAC 




2. ELUCIDATION OF THE 5F- APINAC METABOLIC PATHWAY 
2.1 INTRODUCTION 
New psychoactive substances (NPS) or “designer drugs” are the trending drugs of today’s drug 
market. They are chemical derivatives or analogues of classic illicit substances designed to produce 
effects similar to that of illegal drugs [86]. The relentless modification of chemical structures by 
clandestine laboratories presents a challenge to legal processes, as they always manage to be one 
step ahead. In addition, it presents a threat to public health. Even small modifications in the chemical 
structures of these drugs can result in differences in biological activity and pharmacokinetic 
properties, and represent a challenge for identification [89]. Moreover, the psychoactive effects of 
terminally fluorinated analogues of synthetic cannabinoids (SCs) generally showed CB1 receptor 
potency higher than that of non-fluorinated analogues (~ 2–5 times), and thus, may have a higher 
impact on health risks [90]. There is also a need to develop highly sensitive and accurate analytical 
technologies for the identification and quantitation of metabolites associated with NPS [91]. 
Advances in laboratory methodologies and scientific international collaboration are needed to tackle 
this problem [92,93]. Elucidating the metabolic pathways of these new drugs is highly important for 
toxicological risk assessment in order to develop drug screening procedures for the detection of 
drugs and their metabolites in blood or urine [94].  Since drug concentrations in the body depend on 
metabolism, more information about it would help in the medical treatment of poisoning or 
intoxication cases. From an analytical perspective, knowing the fragmentation and specific product 
ions helps towards the faster elucidation of similar, but unknown related compounds. For instance, 
in distinguishing between different compounds of the same family of NPS such as synthetic 
cannabinoids (SC). Metabolic path elucidation is very relevant since NPS are fast appearing in the 
market and scientists are trying to identify and characterise them at the same rate in which they 
appear. This speedy appearance is due to the relentless modification of chemical structures by 
clandestine laboratories [95,96]. 
SCs were originally developed for research purposes, but rapidly turned out to be used as drugs of 
abuse, mostly as an alternative to cannabis. To achieve psychoactive effects, chemical additives are 
sprayed onto dried plant materials to be sold as a legal alternative to cannabis [97]. To avoid 
regulations, the products are labeled as “not for human consumption“. These substances have 
structural features similar to tetrahydrocannabinol (THC), which enables them to bind to CB1 and 
CB2 receptors, triggering cannabis-like effects (i.e., paranoia, sedation, anxiety, euphoria, and 
impaired sense of time as demonstrated in in vivo studies [98]). However, they are more powerful 
receptor agonists than THC, thereby increasing the intensity of psychosis, agitation, and 
sympathomimetic effects [99,100]. The clinical toxicity of SCs is partly similar to the one provoked 
by amphetamines [101,102]. Typical symptoms of SC consumption are: vomiting, hallucinations, 
tachycardia, excitement, hypertension, and drowsiness [99,102]. Poisonings with SCs usually 
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manifest brain edema due to hyponatremia, hypherthermia, seizures, and serotonin syndrome [103]. 
Usually, SC intake occurs by smoking using a cigarette or a cannabis pipe. They are extensively 
metabolised, and their main metabolites are hydroxyl or carboxyl derivatives of the aromatic ring or 
the N-alkyl chain. JWH-018 was the most popular first-generation SC [90], closely followed by 
second-generation SCs, such as AB-PINACA, AKB-48, and ADB-PINACA [93,104] 
Finally, the collaboration between countries in tracking trends in the illicit market is of paramount 
importance for tackling the NPS problem. The EU Early Warning System (EUEWS), set by the 
European Monitoring Center for Drugs and Drug Addiction (EMCDDA), has been internationally 
recognized for its capability to identify and respond to the emergence of NPS [105]. 
In the present work, a new SC,  5F-APINAC (adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole- 3-
carboxylate) which is the fluorinated analogue of APINAC (adamantan-1-yl 1-pentyl-1H-indazole-3-
carboxylate) was studied [93]. The fluorine substitution at the 5-pentyl position of 
pentylindazole/pentylindole is a popular modification that enhances the drug’s stability, potency, and 
half-life [93,104]. APINAC and its metabolic reactions have already been characterised [88,106] 
Because one of the most common metabolic routes is defluorination, several metabolites of 5F-
APINAC are expected to be similar to those of APINAC. APINAC and 5F-APINAC are structurally 
similar to AKB-48 (APINACA) and 5F-AKB-48 (5F-APINACA) [87], respectively (Figure 19). The 
unequivocal identification of 5F-APINAC-associated metabolites as potential markers of its intake is 
Figure 19. Structures of APINAC, 5F-APINAC, AKB-48, and 5F-AKB-48 
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critical in the detection of suspected SC consumption [93]. To our knowledge, no data related to 5F-
APINAC metabolism has been reported. The aim of the present study was to investigate the 
metabolism of 5F-APINAC in human liver microsomes (HLMs) (in vitro study) and in a rat model (in 
vivo study) using liquid chromatography–ion trap mass spectrometry (LC–IT-MS) and liquid 
chromatography–quadrupole time- of-flight tandem mass spectrometry (LC–QTOF-MS/MS). 
2.2 MATERIALS AND METHODS 
2.2.1 REAGENTS 
Ultra-pure water was purchased from Biosolve (Valkenswaard, the Netherlands); diethyl ether and 
acetone from Medkhimprom (Moscow, Russia); acetonitrile from J.T. Baker (Deventer, the 
Netherlands); methanol and ethyl acetate from Merck (Darmstadt, Germany); β-glucuronidase from 
E. coli K12 (solution in 50% glycerol) from Roche Diagnostics (Mannheim, Germany); and 5F-
APINAC (purity ≥ 98%) from Cayman Chemical (Ann Arbor, MI, USA). All other chemicals used in 
this study were purchased from Sigma-Aldrich (St. Louis, MO, USA). Solid-phase extraction (SPE) 
was performed using Oasis HLB columns (60 mg × 3 mL; Waters, Milford, MA, USA). 
2.2.2 IN VITRO & IN VIVO STUDIES 
For the in vitro study, the incubation procedure was performed in accordance with the manufacturer’s 
protocol for Human Liver Microsomes (HLMs) [105]. For the in vivo study, urine from male Sprague–
Dawley rats was collected 3, 6, and 24 h after 5F-APINAC administration. Samples were stored at -
80°C until the analysis was performed. Both samples were prepared by an experienced pharmacist 
with experience in working with animals and in vitro studies. All animal procedures were approved 
by the Institutional Animal Care and Ethical Committee of the Research Center for Molecular 
Diagnostics and Therapy at Sechenov University, Moscow, in accordance with principles of good 
laboratory practice [OECD Principles on GLP. C (97)186 Final], following the European Union 
directive principles of laboratory animal care guidelines (2010/63/EU). 
2.2.3 PREPARATION OF RAT URINE SAMPLES 
The urine samples were divided into two aliquots. A 1 mL volume of 0.8 M phosphate buffer (pH 6.5) 
containing 30 μL β-glucuronidase was added to 0.5 mL of urine (first aliquot). After incubation at 
37°C for 60 min and pH adjustment (pH 2.0–2.5) using hydrochloric acid, the samples were extracted 
with 1 mL of ethyl acetate. For the second aliquot, the phosphate buffer did not contain β-
glucuronidase and the addition of the enzyme and incubation steps were omitted. Following the 
evaporation of the organic layer at 70°C in a solid-state heater, the residue was reconstituted in 100 
μL of MeOH/ H2O (1:1, v/v) for instrumental analyses. 
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2.2.4 TENTATIVE THEORETICAL METABOLIC PATHWAY  
Theoretical predictions of the possible metabolites were made based on the similarity of structure 
between APINAC and 5F-APINAC, AKB-48 (APINACA) and 5F-AKB-48 (5F-APINACA) [87], and 
the already elucidated metabolic pathway of APINAC [88]. With help of the ChemDraw Ultra software 
(Version 12.0, Cambridge Software) theoretical fragmentations of the metabolites were predicted. 
The theoretically predicted metabolites were also drawn, and using the fragmentation tool, different 
fragmentation possibilities were explored. Together with the formula and exact mass of the said 
fragments, all the theoretical proposals were compared with the experimental data. 
2.2.5 LC–IT–MS (TOXTYPER) ANALYSES 
The LC–IT–MS analyses were performed using ultra high-performance liquid chromatography 
(UHPLC) Dionex UltiMate 3000 (Thermo Scientific, Waltham, MA, USA) coupled with amaZon speed 
mass spectrometer (Bruker, Billerica, MA, USA). Chromatographic separation of the analytes was 
achieved on a Thermo Scientific Acclaim RSLC 120 C18 of 120Å column (100 × 2.1 mm, i.d., particle 
size 2.2 µm) (Thermo Scientific) guarded by a Vanguard BEH C18 column (20 × 2.1 mm. i.d.; 
Waters). The column temperature was set at 40°C and the autosampler at 8°C. Mobile phase A 
consisted of ultra-pure H2O with 2 mM ammonium formate, 1% acetonitrile, and 0.1% formic acid. 
Mobile phase B consisted of acetonitrile, 2 mM ammonium formate, 0.1% formic acid, and 1% H2O. 
The flow rate was set to 0.5 mL/min. Gradient elution was performed as follows: 0.0–1.0 min 1% B; 
1.0–8.0 min 1–95% B, linear; 8.0–9.0 min 95% B; 9.0–9.06 min 95–1% B, linear; 9.06–11 min 1% 
B. The total run time was 11 min. Electrospray ionisation (ESI) was performed using positive mode. 
Scan range was set at m/z 70–800. Data were collected in data-dependent MSn acquisition mode.  
2.2.6 LC–QTOF ANALYSES 
LC–QTOF experiments were performed for confirmation purposes on a Bruker Elute series of 
UHPLC coupled with quadrupole time-of-flight mass spectrometer UHR- QTOF (Ultra-high resolution 
QQ-time-of-flight) maXis impact (Bruker). Chromatographic separation of the analytes was achieved 
using an Intensity Solo 2 C18 1.8 µm, 100 × 2.1 mm column (BRU-18C182-100 μm; Bruker) and a 
1.7 µm ACQUITY UPLC BEH C18 pre-column (Waters). The column oven temperature was set at 
40°C and the autosampler’s at 4°C. Mobile phase A consisted of 1% methanol in H2O, 5 mM 
ammonium formate, and 0.01% formic acid. Mobile phase B consisted of methanol, 5 mM 
ammonium formate, and 0.01% formic acid. The flow rate was 0.2 mL/min. Gradient elution was 
performed as follows: 0.0–1.0 min 4% B; 1.0–6.0 min 50% B; 6.0–10.0 min 50–99.9% B; 10.0–10.05 
min 99.9–4% B; 10.05–14.0 min 4% B. Ionisation was performed using ESI-source operation in 
positive mode and mass scans ranged from m/z 30–1000. The ion source parameters were set as 
follows: capillary voltage 4500 V; N2 temperature (drying gas) 220°C; flow rate 8 L/min; collision 
energy 7.0 eV. The total run time of the analysis was 20 min. Metabolite search was based on the 
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exact masses of the precursor ions of putative compounds and on typical product ions in auto MS/MS 
and target MS/MS modes. 
2.3 RESULTS  
The appreciable metabolites were found up to 6 h after administration. No metabolites were found 
24 h after, which is in accordance with the extensive metabolism of SCs [104]. An overview of the 
proposed metabolic reactions associated with 5F-APINAC is presented in Figure 20. Extracted ion 
chromatograms for the metabolites associated with 5F-APINAC found in vitro and in vivo are 
presented in Appendix II Supplementary Figs. 1 and 2, respectively. 
2.3.1 LC–IT–MS AND LC–QTOF ANALYSES 
Fifteen 5F-APINAC-associated metabolites, including a phase II metabolite M8, were tentatively 
identified by LC–IT–MS and LC–QTOF–MS/MS following 5F-APINAC administration to rats (Figure 
21, Figure 22). The structures of the metabolites were predicted with high accuracy and later 
corroborated by studying the fragmentation pattern of the product ions. Table 16 shows the proposed 
biotransformations, retention time, m/z of precursor and product ions, molecular formulae, and the 
mass errors of the proposed metabolites. 5F-APINAC eluted at 13.3 min and all the metabolites 
eluted between 5.1 and 12.5 min. 5F-APINAC had a protonated molecular ion at m/z 385 with its 
consequent product ion at m/z 135, corresponding to an adamantyl ring residue generated by the 
cleavage of the ester group (Figure 21 a). Identified metabolites were results of carboxylation, 
hydroxylation, ester hydrolysis, oxidation, or glucuronidation. Hydroxylation was the most common 
biotransformation. Identified metabolites were: 1-adamantanol metabolites (M1–M6), oxidative 









Table 16. Metabolites associated with 5F-APINAC identified in in vivo and in vitro. 



















5F-APINAC    Parent compound 13.3 385.2285 385.2291 C23H30FN2O2+ 4.4 135.1180 C10H15 4.4 
In vitro 
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12.5 383.2332 383.2329 C23H31N2O3+ 0.8 135.1171 C10H15 -5.2 





















































Figure 21. Product ion spectra of metabolites associated with 5F-APINAC recorded by LC–QTOF 
(part 1). The diamond shows the location of each protonated molecular ion of the metabolites. a 5F-





Figure 22. Product ion spectra of metabolites associated with 5F-APINAC recorded by LC–QTOF 
(part 2). a M7, b M8, c M9, d M10, e M11, f M12, g M13. 
2.3.2 HLM INCUBATION OF 5F-APINAC 
5F-APINAC was rapidly ester-hydrolysed when incubated with HLMs. It was fully converted after 3h 
of incubation. Utilisation of the NADPH-dependent system presumably resulted in the formation of 





2.3.3 METABOLIC PATHWAY 
Monohydroxylation 
M1 was found in the in vitro and in in vivo experiments up to 3h. It was proposed as a 
monohydroxylated metabolite. The protonated molecular ion was found at m/z 401 and eluted at 
10.9 min. The product ions at m/z 151 indicate that the monohydroxylation was on its adamantyl 
ring. The ion at m/z 133 indicates the loss of water from the adamantyl ring (Figure 21.b). 
Dihydroxylation 
M2 and M3 were proposed as dihydroxylated metabolites. The protonated molecular peak was found 
at m/z 417. M2 was only found in vitro, whereas M3 was found both in vitro and in vivo up to 6h after 
administration. Regarding M2, two product ions were found at m/z 151 and 133. This supports 
monohydroxylation occurring in the adamantyl ring and dehydration from the product ion at m/z 151. 
The ion at m/z 267 indicates the presence of the hydroxyl group on the N-fluoropentyl side chain, 
while m/z 249 corresponds to its dehydrated derivative (Figure 21.c). 
M3 product ion spectrum showed fragments at m/z 167, 149, and 131. The product ions support that 
two hydroxylations occurred in the adamantyl ring. The fragment at m/z 167 correspond to 
adamantanediol, and the product ions at m/z 149 and 131 indicate two consecutive dehydrations 
from the product ion at m/z 167. At the same time, the product ion at m/z 251 and the ion at m/z 233 
prove the absence of hydroxylation at N-fluoropentyl side chain (Figure 21.d). 
Trihydroxylation 
M4.1, M4.2, and M4.3 were proposed as the trihydroxylation metabolites. They were found both in 
vitro and in vivo up to 6h after administration. Their protonated molecular ions appeared at m/z 433, 
and their retention times were 6.8, 7.7 and 8.2 min, respectively (Appendix II Fig. S1). All metabolites 
had the same spectrum, which suggests that the hydroxylation on the N-fluoropentylindazole moiety 
chain occurs in three different places, and that the adamantyl moiety undergoes two hydroxylations. 
The product ions at m/z 267 and 167 may characterise the breakdown of the ester bond. The one at 
m/z 167 is thought to belong to adamantanediol, and the product ions at m/z 149 and 131 indicate 
two consecutive dehydrations from the product ion at m/z 167. The ion at m/z 267 is thought to 
belong to the 3-carboxy-1-(5-fluorohydroxypentyl)-1H-indazole. The ions at m/z 249 and 233 indicate 
two consecutive dehydrations from m/z 267 (Figure 21.e). 
Monohydroxylation and oxidation 
M5 was only found in vitro up to 3h after administration. It eluted at 8.9 min and had its protonated 
molecular ion at m/z 415. Its spectrum showed two product ions at m/z 151 and 133 belonging to 
the monohydroxylated adamantyl ring and its dehydration, respectively (Figure 21.f). 
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Dihydroxylation and oxidation 
M6 was found in vitro with a protonated molecular ion at m/z 431. This metabolite indicates the 
presence of carbonyl and hydroxyl groups at the adamantyl ring (m/z 165) and hydroxylation at the 
5-fluoropentyl side chain (m/z 267). Moreover, the ion at m/z 147 is related to dehydration from the 
ion at m/z 165 (Figure 21.g). 
Ester hydrolysis 
Because it has been reported that SCs containing an ester group (i.e.,  BB-22,  PB-22,  5F-PB-22,  
APINAC, and NM-2201) are extensively hydrolysed [107,108], 5F-APINAC was expected to undergo 
a similar process. M7 was found in the in vitro and in vivo experiments up to 6h after administration. 
Moreover, it was one of the principal metabolites found in rat urine. It eluted at 7.2 min, and its 
precursor ion was identified at m/z 251. The ion at m/z 233 corresponds to the dehydration of the 
protonated molecular M7, while m/z 163 and 145 are associated with the consistent loss of the pentyl 
side chain and dehydration, respectively. Natural loss of hydrogen fluoride at m/z 233 resulted in the 
formation of a product ion at m/z 213. At the same time, an ion at m/z 177 was formed by fluorine 
rearrangement [109] (Figure 22.a). 
Glucuronidation 
M8 was identified as a phase II metabolite in the in vivo study, which is a glucuronide conjugate. Its 
protonated molecular ion was found at m/z 427. M8 underwent several fragmentations in the ion 
source, which resulted in the appearance of product ion m/z 251 corresponding to the protonated 
molecule of M7. As reported by Savchuk et al. [88], this is a property common to phase II metabolites 
(ester of glucuronic acid). Further product ions were found at m/z 233, 213, 177 and 145, as 
described for M8. Another fragment with m/z 391 could be associated with two dehydrations of the 
M8 molecular ion (Figure 22.b). 
Ester hydrolysis followed by monohydroxylation 
M9 was identified only in the in vivo study up to 6h after administration. It eluted at 6.7 min and was 
identified from its protonated molecular ion at m/z 267. The product ion spectra contained ions at 
m/z 249, 231, 175, and 145. The product ion with the highest intensity at m/z 249 corresponds to the 
metabolite after dehydration. The fragment at m/z 231 was generated by dehydration from its 
precursor ion at m/z 249. The ion at m/z 175 strongly suggests a cleavage between the N-α and β 
carbons of the hydroxylated N-fluoropentyl group in this metabolite (Figure 22.c) 
Oxidative defluorination (hydroxyl formation) 
M10 was only found in vitro and had its protonated molecular ion at m/z 383. M10 was proposed as 
the metabolite after a loss of fluorine and the consecutive addition of a hydroxyl group. The 
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adamantyl cation at m/z 135 was the only fragment in the product ion spectra which suggests an 
unmodified adamantyl ring. Such a process has also been reported in 5F-AKB-48, XLR-11, and AM-
2201 [98] (Figure 22.d). 
Oxidative defluorination (aldehyde or carboxyl formation) and monohydroxylation 
M11 (only found in vitro) showed a protonated molecular ion at m/z 397 that was associated with 
consequent oxidation of a hydroxyl group to aldehyde and the addition of a hydroxyl group on the 
adamantyl ring (m/z 151). The fragment at m/z 133 corresponds to dehydration from m/z 151, and 
the ion at m/z 247 to the breakdown of the ester bond (Figure 22.e). 
M12 found in vitro and in vivo showed a protonated molecular ion at m/z 413, probably followed by 
oxidation to carboxyl group via the aldehyde (M11) and the addition of a hydroxyl group on the 
adamantyl ring (m/z 151). The fragment at m/z 133 corresponds to dehydration from m/z 151 (Figure 
22.f). 
Oxidative defluorination (carboxyl formation) and dihydroxylation 
M13 was found in vitro and in vivo up to 6h after administration and had its protonated molecular ion 
at m/z 429 which corresponds to the loss of fluorine followed by introduction of a carboxyl group and 
addition of two hydroxyl groups on the adamantyl ring. The fragment at m/z 167 is thought to be due 
to adamantanediol, and the ions at m/z 149 and 131 indicate two consecutive dehydrations from the 
product ion at m/z 167. The less intense fragment at m/z 245 could belong to the fragment appearing 
after cleavage of the ester bond (Figure 22.g). 
Metabolites found in negative ionisation mode 
M10 had two product ions corresponding to the indazole moiety (m/z 117) and the 1-fluoro-5-(1H-
indazol-1-yl)pentan-3-ol fragment (m/z 221). M7 had its protonated molecular ion at m/z 249. The 
fragment corresponding to indazole appear at m/z 117 and the fragment at m/z 205 is thought to 
belong to the C-C cleavage between the indazole moiety and the carboxyl group. M13 (m/z 427) had 
only one fragment in its product ion spectrum. It is suggested that m/z 327 is a consequence of C-N 
cleavage, detaching the carbon chain from the rest of the molecule. 
2.4 DISCUSSION 
Although the in vivo metabolism of 5F-APINAC in humans was not characterised, utilisation of in 
vitro models of HLMs together with in vivo experiments in rats is considered the first step for 
characterising the metabolism of new drugs. The non-fluoro counterpart APINAC (AKB57) is well 
known to have circulated and was first detected in smoking mixtures on the black market in South 
Korea [106]. In September 2016, a powdery substance (1.97 g, purity 72% investigated by high-
performance liquid chromatography) containing APINAC was confiscated in Saratov Region 
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(Russia) in the course of a police investigation [88]. However, to our knowledge, at the international 
level, APINAC is subjected to control only in the Republic of Belarus and Japan. 
As for the fluorinated analogue of APINAC, it is easily expected that the mode of drug action is 
enhanced, because the fluorine substitution at the 5-pentyl position of pentyl- 
indazoles/pentylindoles was reported to enhance the drug’s stability, potency, and half-life [93,104]. 
Because of the worldwide lack of regulation and the high potency of 5F-APINAC, it is probable that 
this drug will circulate widely. Thus, it is important to characterise the metabolism of 5F-APINAC. 
Due to the unavailability of authentic human urine specimens with 5F-APINAC and its metabolites, 
experiments with HLMs in vitro, and with rat urine in vivo collected 3, 6, and 24h after administration 
of 5F-APINAC were carried out instead. There are two papers describing the metabolism of APINAC, 
the non-fluoro counterpart of 5F-APINAC [88,107]. If the fluorine at the terminus of the pentyl side 
chain is intensively attacked for defluorination at the initial/early stage of metabolism, the metabolites 
of 5F-APINAC common to those of APINAC will appear. However, in contrast to our expectation, we 
found that M12 was the only metabolite common to both SCs. The metabolic profiles for 5F-AKB-48 
and AKB-48, the compounds analogous to 5F-APINAC and APINAC, respectively (Figure 19), were 
also studied by Vikingsson et al. [110]. They concluded that only a few identified metabolites were 
shared between AKB-48 and 5F-AKB-48. Therefore, it is easy to discriminate between 5F-APINAC 
and APINAC, and also between 5F-AKB-48 and AKB-48 by checking multiple metabolites for each 
SC. In addition, it should be pointed out that N-5-fluoropentylindazole-3-carboxylic acid (M7), which 
appeared as an abundant peak in both in vitro and in vivo experiments, is not a metabolite specific 
to 5F-APINAC, but can also be most probably produced from 5F-SDB-005, an indazole carboxylate 
SC with a 5-fluoropentyl side chain. 
Based on the experiments, the most prevalent metabolite, which will be easily detected in human 
urine, is M7. With this metabolite alone, it can be concluded that the SC has a 5-fluoropentyl side 
chain and is suggestive of the consumption of 5F-APINAC or 5F-SDB-005, although the use of a 
new/unknown 5-fluoropentylindazole carboxylate SC cannot be ruled out. In addition to M7, M4.1, 
or M13 having an adamantyl ring, it is essential to definitively prove 5F-APINAC consumption. 
2.5 CONCLUSION 
In the present study, 15 metabolites associated with the novel SC 5F-APINAC were described. 
Tentative identification of the metabolites was performed through in vitro incubation with HLMs and 
in vivo with rat urine after intravenous administration of the drug. The predominant metabolic 
reactions were ester hydrolysis remaining in both in vitro and in vivo experiments and resulting in 
the formation of M7 (5-fluoropentylindazole-3-carboxylic acid). Other metabolic transformations 
included mono-, di- and trihydroxylation of the adamantyl ring and N-fluoropentylindazole moiety, 
oxidation of the N-fluoropentyl side chain, oxidative loss of fluorine and glucuronidation, as well as 
67 
 
combinations thereof. The discovered metabolites may serve for future studies and are likely to be 
incorporated into routine analytical screening methods as urine markers of 5F-APINAC consumption. 
2.6 LIMITATIONS AND FUTURE RESEARCH 
The metabolism of 5-F APINAC was not characterised in humans. Utilisation of in vitro models of 
HLM together with in vivo experiments in rats is considered an optimal choice for characterising the 
metabolism of new drugs. However, in vitro incubation simulates the metabolic transformation only 
in the liver, whereas metabolism in rats may differ from humans. Rat models cannot fully replace 
controlled human studies. Although the experiments were not performed in humans, the use of the 
murine model presented the advantage of being able to study the metabolism of the drug in time 
series, which is difficult to conduct in humans due to ethical considerations. It is important to point 
out that the research was limited in terms of the lack of identification of the exact positions of the 
modifications. It was only possible to deduce whether a modification was located on the adamantyl 
group or on the pentylindazole moiety. Future studies should ideally include experiments based on 




3. DEVELOPMENT AND VALIDATION OF A NEW METHOD FOR THE 
DETERMINATION OF 13 SECOND-WAVE SYNTHETIC CANNABINOIDS IN 
HAIR 
3.1 INTRODUCTION 
Novel psychoactive substances (NPS) have been designed to mimic the psychoactive effects of 
common illicit drugs. However, their different chemical structures hinder their detection during 
standard toxicological screenings. The consumption of these psychoactive substances is known as 
a “legal high” since they escape current law restrictions. In recent years, the EMCDDA has reported 
an increased use of these substances throughout the European Union. The main concern is the 
increased psychoactive effects compared to classical drugs, which have life-threatening side effects. 
This increased potency is a result of the higher binding capacity of these NPS to CB1 and CB2 
receptors [111]. During the pandemic, the illicit drug market was disrupted but quickly recuperated, 
with an increase of sales in the dark markets once the restriction measures were relaxed.  Moreover, 
some health conditions linked to drug use together with drug sharing, such as a sharing a cannabis 
joint, is now a greater health risk than before [112]. 
Synthetic cannabinoids (SCs) are one type of NPS that mimic the effects of Δ9-Tetrahydrocannabinol 
(THC). SCs are in the top two substances being seized and the largest group of NPS being 
monitored, as per the latest report of the EMCDDA [112]. The first SC detected was JWH-018, the 
most popular first-generation SC, followed by the second-generation of SCs, such as ADB-PINACA, 
UR-144, 5F-PB-22, AB-FUBINACA, AKB-48 [93]. They do not contain cannabis but produce similar 
effects due to the binding to the CB1 and CB2 receptors. They are produced by spraying chemical 
additives on dried plant products and are sold as a legal alternative to cannabis [113]. They are 
available as incenses, tea, food additives, herbal mixtures, energy drinks, and scents [114]. Specific 
effects of SCs are hard to predict due to the lack of pharmacokinetic information. However, it is very 
well-known that all SCs are extensively metabolised [115]. Typical intoxication symptoms include 
vomiting, abdominal or flank pain, nausea, and hypertension. There is little clinical information, but 
acute kidney injury has been associated with SC use [93].  
On account of the fast emergence of new SCs where only a side chain is modified (large structural 
diversity) together with an increase in consumption of these herbal mixtures, there is a need to 
develop fast and high throughput analytical screening methods for their reliable detection. To date, 
SCs have been determined in several biological specimens such as serum, hair, urine, and blood 
[114–120]. The method of choice is liquid chromatography coupled with different types of mass 
detection, such as, QTOF, Qtrap, and QQQ [114–120]. Recently, Bruker developed a high 
throughput LC–MS system, called Toxtyper®, which operates as screening device using libraries 
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that contain more than 4000 compounds, including their main metabolites. These libraries are 
constantly updated with the emergent NPS substances [121]. 
As mentioned above, several biological specimens have potential to be used for the analysis of SCs. 
It is a well-known fact that keratin in the hair’s root contains several xenobiotics that are also present 
in blood and are protected from environmental factors as well as metabolism. Therefore, it seems 
highly suitable to use hair as the chosen specimen for the identification of SCs [114]. To the best of 
our knowledge, the only method which uses this technology for the toxicological screening of hair 
does not include synthetic cannabinoids [122]. 
The aim of the present work is the development and validation of a screening and semi-quantitative 
method for 13 second-wave SCs in hair based on liquid chromatography coupled with IonTrap (LC–
QIT–MS): (R)-5F-ADB, 5F-PB 22, 5Cl-AB-PINACA, 5F-AKB-48, 5F-APP-PICA (PX-1), 5F-APP-
PINACA (PX-2), 5F-CUMYL-PINACA, AB-CHMINACA, AB-FUBINACA, ADB-FUBINACA, MDMB-
CHMICA, MMB-2201, and UR-144. The method was applied to hair samples from subjects who have 
tested positive for one or several other illegal drugs. 
3.2 MATERIALS AND METHODS 
3.2.1 REAGENTS 
Standard solutions of (R)-5F-ADB, 5F-PB 22 ,5Cl-AB-PINACA, 5F-AKB48, 5F-APP-PICA (PX-1), 
5F-APP-PINACA (PX-2), 5F-CUMyL-PINACA, AB-CHMINACA, AB-FUBINACA, ADB-FUBINACA, 
MDMB-CHMICA, MMB-2201, and UR-144 were purchased from Comedical (Trento, Italy). Their 
structures, MRM transitions, and retention times are displayed in Table 17. D5-diazepam was 
purchased from Cayman chemicals (Michigan, US) and used as IS. 
Ammonium was provided by AnalaR in salt form (NH4Cl) (Merck, Darmstadt, Germany). Acetonitrile 
(ACN), methanol (MeOH), and 2-propanol for UHPLC were purchased from VWR Chemicals 
(Fontenay-Sous-Bois, France). 98% formic acid for LC–MS and Dichloromethane (CH2Cl2) for HPLC 
were obtained from Merck KGaA (Darmstadt, Germany). Absolute ethanol was provided by Carlo 
Erba Reagenti (Milan, Italy). Ultrapure water was obtained from an ELGA VEOLIA (Lane End, High 
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Analysis were performed on a Toxtyper® LC/IT–MS system. The instrument consisted of an Elute 
UHPLC system coupled with amaZon speed® ion trap with three different sources: electrospray 
ionisation sources (ESI), atmospheric pressure chemical ionisation (APCI), and IonBoosterTM (iB) 
(Bruker Daltonics, Bremen, Germany). Nitrogen was used as a nebulising and drying gas. The 
source settings were optimised in order to achieve the highest and most reproducible signal of the 
analytes. 
Two analytical columns were used: Acclaim™ RSLC 120 C18 (2.1x100 mm, 2.2 μm, 120 Å) from 
Thermo Fisher (Idstein, Germany) and Kinetex C18 (2.1X100 mm, 2.6 μm, 100Å) from Phenomenex 
(California, US). The column oven was kept at 40ºC. Mobile phase A (aqueous) contained 1% ACN, 
0.1% formic acid and 2 mM ammonium formate. Mobile phase B (organic) contained 1% H2O, 0.1% 
formic acid and 2 mM ammonium formate. Gradient elution was performed as follows: 0-1 min: 20% 
B, 1-2.50 min: 20-60% B linear, 2.50-4 min: 60-65 %B linear, 4-5.50 min: 65% B, 5.50-8 min: 65-
99%, 8-10 min: 99%, 10-10.20 min: 99-20% B, 10.20-12 min: 20% B. The flow rate was 0.5 mL/min, 
and the injection volume was 5 µL. The MS was operated in AutoMSn from 70–800 amu.  
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The method already provided by the company was optimised with the different sources. SC 
identification was done through the Toxtyper® software based on retention time (RT), full scan MS, 
MS2, and MS3 using the synthetic cannabinoids spectral library. The acquired MSn spectra are 
compared against the library and a purity score is generated, which symbolises the degree of 
consistency between the library and the experimental spectrum. The purity has to be at least 700 for 
a positive identification and 1000 means 100% identity. In the present work, purity must be above 
850 and only a ΔRT= ±0.3 min was allowed for considering the SC identified by the Toxtyper® system. 
3.2.3 SOLUTIONS AND CALIBRATION CURVE PREPARATION 
For the stock solution, a mix with all SCs was prepared by diluting adequate volumes of the SC with 
MeOH to a concentration of 1 µg/mL. For the IS solution, d5-diazepam was diluted to 1 µg/mL with 
MeOH. Both solutions were stored at –20 °C. The hair calibration standards (3, 2, 1, 0.5, 0.3 ng/mg) 
were prepared by adding the adequate amount of SC and 50µL of IS solution (constant concentration 
of IS 1 ng/mg) to 50 mg of blank hair before extraction. 
3.2.4 HAIR SAMPLE PREPARATION 
The method was developed using blank hair samples. The samples were spiked with the mix of SCs 
and the IS at the desired concentration levels. In addition, 11 samples from real cases were used for 
the validation of the methodology. 
Sample preparation was adapted from Hutter et al.[116]. Briefly, 70 mg of blank hair were washed 
with dichloromethane for 5 minutes. They were left to dry for 10 minutes and afterwards they were 
cut and pulverised using the homogeniser instrument (Precellys® Evolution, Bertin instruments). 
Then, 50 mg of the blank hair was weighed in a glass vial and then extracted with 1,5 mL of EtOH 
for 3 hours in an ultrasonic bath. After extraction, the samples were centrifuged for 10 minutes. 
Successively, 1 mL of the solution was transferred to a glass vial and evaporated with N2 at room 
temperature. The dry residue was reconstituted in 100 µL of phases A/B 50/50 (v/v). 
3.2.5 METHOD VALIDATION 
Firstly, the suitability of the two available columns (1 and 2) for the successful and unequivocal 
separation of all 13 SCs was evaluated. Secondly, the three different available sources were 
evaluated based on the intensity of the signal for all 13 SCs. For each source, their MS parameters 
were optimised and then the intensities of the 13 SCs were compared for each optimised source. 
Thirdly, after selecting the column and source, the method was validated according to method 
validation guidelines suggested by Polettini [71] for the quantification of SCs in human hair samples. 
Validation samples were prepared by spiking blank hair with the IS and SC mixture prior to extraction. 
Selectivity was assessed by measuring three blank hair samples in triplicate. A calibration curve was 
evaluated by six replicate measurements for each point. Accuracy and precision studies were carried 
out by analysing three samples at high (2 ng/mg), middle (1 ng/mg), and low (0.5 ng/mg) 
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concentrations for five days with six replicates for each concentration point. LOD was determined as 
the lowest concentration at which the analyte could be identified with S/N ≥ 3. 
Matrix effects, process efficiency, and extraction recovery were assessed following the guidelines of 
Matuszewski [123]. The matrix effect (ME) is calculated as the ratio between the peak areas 
determined by the analysis of hair samples fortified with the SCs after extraction and the standards 
in mobile phase (50/50, v/v). The process efficiency (PE) is calculated as the ratio between the peak 
areas determined by the analysis of hair samples fortified with the SCs before extraction and the 
standards in mobile phase (50/50, v/v). The extraction recovery (R) was calculated as the ratio 
between the peak areas determined by the analysis of hair samples fortified with the SCs before 
extraction and the peak areas determined by the analysis of hair samples fortified with the SCs after 
extraction. 
3.2.6 REAL CASES 
Authentic hair samples were collected from subjects tested positive for one or more of the following 
illegal drugs: cocaine and its metabolites cocaethylene, benzoylecgonine and ecgonine methyl ester, 
codeine, amphetamines, MDMA, MDA, ketamine, nor-ketamine, morphine, methadone and its 
metabolite EDDP, heroine metabolite 6-MAM, dihydrocodeine (DHC). No information about the use 
of SC was available. The samples were prepared following the developed method. 
3.3 RESULTS AND DISCUSSION 
3.3.1 COMPARISON OF THE TWO COLUMNS 
Two columns were tested to evaluate their suitability for the best separation of all the SCs. In 
particular, the columns recommended by the equipment producer, Acclaim™ and Kinetex, where 
both evaluated (Column 1 and Column 2, respectively). They differ for particle sizes and pore sizes: 
2.2 µm (column 1) and 2.6 µm (column 2), and 120 Å (column 1) and 100 Å (column 2), respectively. 
As shown in Figure 23, with column 1, separation occurs in 8 minutes but between 3.35–3.70 min 
many analytes elute in overlapping peaks. In addition, some compounds such as 5F-ADB and 5F-
PB-22 show two peaks for the same compound. On the contrary, column 2 was the best choice since 
the separation takes place in a shorter time (7 minutes) and in column’s 2 cluster area, only six 
compounds elute and are clearly very well separated. Therefore, column 2 was selected as the best 





Figure 23. Comparison of column 1 (top) and column 2 (bottom) for the separation of 13 SCs. 
3.3.2 COMPARISON OF ESI, IB, AND APCI SOURCES 
In this study, three different sources were tested in order to evaluate their suitability for the analysis 
of SCs. In addition to the common ESI and APCI atmospheric pressure sources, ionBooster (iB) was 
tested. The IB is a heated ESI source in the spray zone which increases the desolvation process 
when using flows rates higher than 200 µL/min, resulting in improved detection limits. 
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The SCs were at a concentration of 200 ng/mL for all source tests. Information about the optimised 
parameters and the range of optimisation can be found in Table 18.  
Table 18. Source settings for the optimisation of all three sources with the SynnCann method. The 
values in bold are the optimised values, (N/A not applicable). 
 ESI iB APCI 
Capillary voltage (V) 
1000, 3000, 4500 1000, 3000, 4000 2000, 4000, 5500 
End of plate offset (V) 100, 500, 1000 300, 600, 900 1000, 2000, 3000 
Corona (nA) N/A. N/A 5000, 15000, 30000 
Charging volt N/A. 300, 600, 900 N/A 
Nebuliser (bar) 1, 3, 4 1, 3, 4 1, 3, 4 
Dry gas flow (L/min) 3, 7, 11 3, 7, 11 3, 7, 11 
Dry gas temp (ºC) 60, 100, 160 60, 100, 160 60, 100, 160 
Vaporiser temp (ºC) N/A 250, 350, 450 250, 350, 450 
 
The criteria followed for choosing the best source was highest intensity and if intensities were similar, 
the source with lowest CV (CV<20%) was chosen. As shown in Figure 24 the Ion Booster (iB) source 
is the most adequate for the analysis, with the signal almost double of that obtained with ESI. This 
is in accordance with literature where the iB source has been previously proposed for the successful 
detection of the first wave of SCs [120]. As shown in Figure 24, the ionisation source strongly 
influences the signal intensity.  
 





















Ion Booster ESI APCI
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3.3.3 CALIBRATION, LLOQ, LOD, AND SELECTIVITY 
Selectivity was tested through the analysis of three different drug-free hair samples without IS. Blank 
samples did not reveal any interference with the MRM transition of the analytes.  
For all compounds, linearity was assessed in the range of 0.3-3 ng/mg. The limit of detection (LOD), 
expressed as S/N>3, was 0.0625 ng/mg for all the compounds except for 5Cl- AB-PINACA, 5F-APP-
PICA (PX-1), 5F-APP-PINACA (PX-2) and AB-CHMINACA for which LODs were 0.125 ng/mg. The 
lower limit of quantification (LLOQ), expressed as S/N>10, was 0.3 ng/mg for all compounds, except 
for 5Cl- AB-PINACA, for which the LLOQ is 0.5 ng/mg. The CVs in both LOD and LLOQ are all below 
20%. As depicted in Table 19, all compounds show very good correlation coefficients, being always 
higher than 0.97. 









(R)-5F-ADB 0.0625 y = 1.358(±4.56)x– 1.097(±7.66) R² = 0.997 
5F- PB 22 0.0625 y = 4.518(±6.77)x – 6.836(±6.75) R² = 0.977 
5Cl- AB-PINACA 0.125 y = 4.137(±1.36)x + 7.285(±2.34) R² = 0.997 
5F-AKB-48 0.0625 y = 1.518(±9.76)x – 1.657(±1.66) R² = 0.988 
5F-APP-PICA (PX-1) 0.125 y = 1.018(±5.36)x – 1.67(±8.96) R² = 0.992 
5F-APP-PINACA (PX-2) 0.125 y = 1.008(±2.86)x- 9.086(±4.76) R² = 0.998 
5F-CUMyL-PINACA 0.0625 y = 2.608(±2.97)x – 1.507(±4.96) R² = 0.970 
AB-CHMINACA 0.125 y = 6.767(±3.66)- 4.926(±6.15) R² = 0.992 
AB-FUBINACA 0.0625 y = 6.757((±6.55)x + 1.676(±1.16) R² = 0.999 
ADB-FUBINACA 0.0625 y = 5.90
7(±6.25)x – 4.316(±1.05) R² = 0.999 
MDMB-CHMICA 0.0625 y = 2.738(±2.37)x – 4.07(±3.96) R² = 0.979 
MMB-2201 0.0625 y = 3.218(±2.57)x – 2.87(±4.36) R² = 0.982 
UR-144 0.0625 y = 2.438(±1.97)x – 3.07(±3.26) R² = 0.982 
 
3.3.4 PRECISION AND BIAS 
Precision and bias results are summarised in Table 20 and Table 21. Intra- and inter-day precision 
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Synthetic 
cannabinoid 































R-5F-ADB 20.1 19.3 23.6 14.6 20.4 16.4 15.9 21.9 17.3 15.5 22.0 21.6 20.3 13.9 13.2 
5F- PB-22 7.1 15.8 12.7 15.6 17.5 13.9 9.7 15.2 6.7 11.3 18.3 15.1 11.6 16.6 20.5 
5Cl- AB-
PINACA 
12.6 16.0 13.3 12.6 15.8 5.1 12.6 18.5 4.5 9.9 13.2 19.4 12.3 23.3 19.4 
5F-AKB-48 15.5 21.3 21.7 15.4 3.3 13.7 11.4 15.7 16.3 10.1 22.2 24.4 12.3 16.5 24.3 
5F-APP-PICA 
(PX-1) 
3.0 14.3 13.6 14.8 19.8 13.8 15.2 11.3 11.7 20.4 10.8 6.5 11.1 5.3 3.0 
5F-APP-
PINACA (PX-2) 
14.6 4.2 6.6 25.0 19.9 7.8 15.6 14.1 19.3 17.9 8.4 21.4 19.2 23.0 21.3 
5F-CUMYL-
PINACA 
22.5 16.2 20.0 21.6 11.9 12.6 13.4 17.1 20.6 12.3 9.9 19.1 20.2 15.2 22.2 
AB-CHMINACA 17.8 19.9 23.5 21.5 14.0 12.1 18.3 11.9 12.2 18.1 12.5 20.5 20.9 21.8 19.3 
AB-FUBINACA 5.3 12.2 8.7 16.6 11.4 20.7 5.4 12.3 17.1 18.5 24.6 16.4 18.1 22.4 18.5 
ADB-
FUBINACA 
13.0 18.9 20.4 12.3 19.4 4.1 21.3 15.0 24.0 10.8 21.5 12.7 22.6 23.7 17.4 
MDMB-
CHMICA 
18.2 15.4 20.3 18.8 21.1 14.3 23.3 22.9 13.6 9.6 9.7 20.3 20.3 9.1 32.2 
MMB2201 11.0 10.4 8.1 18.4 16.7 21.7 17.0 17.7 9.9 9.9 19.6 11.5 10.4 5.3 44.1 
UR-144 14.0 21.2 13.0 22.2 10.9 16.6 19.3 15.5 16.6 12.2 19.1 17.0 23.5 21.0 15.1 
d5-Diazepam 14.0 11.6 9.9 9.5 8.6 14.0 15.4 8.0 47.5 9.2 17.8 11.1 22.2 5.6 14.0 
 Inter-day (5 days) 
Synthetic cannabinoid 2 ng/mg 1 ng/mg 0.5 ng/mg 
R-5F-ADB 
16.0 18.5 11.7 
5F- PB-22 3.0 11.9 12.7 
5Cl- AB-PINACA 23.4 24.4 13.8 
5F-AKB-48 11.2 3.6 13.5 
5F-APP-PICA (PX-1) 7.1 7.8 4.2 
5F-APP-PINACA (PX-2) 5.1 19.6 32.6 
5F-CUMYL-PINACA 20.7 15.0 2.6 
AB-CHMINACA 11.1 23.2 19.1 
AB-FUBINACA 1.1 13.7 9.6 
ADB-FUBINACA 13.4 13.2 12.7 
MDMB-CHMICA 17.1 21.1 11.7 
MMB2201 6.9 12.5 3.3 
UR-144 13.3 16.9 7.5 
d5-Diazepam 10.7 9.0 8.2 
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Table 21. Bias results for the three validation concentrations (n=6). 
Synthetic cannabinoid 
Bias (%) 
2 ng/mg 1 ng/mg 0.5 ng/mg 
R-5F-ADB 9.4 -7.9 16.3 
5F- PB-22 -20.8 -18.9 -19.9 
5Cl- AB-PINACA -16.5 16.0 19.6 
5F-AKB-48 -8.9 -9.3 -17.7 
5F-APP-PICA (PX-1) 8.0 13.3 19.4 
5F-APP-PINACA (PX-2) 5.0 19.8 9.0 
5F-CUMYL-PINACA -19.9 -0.5 18.6 
AB-CHMINACA 13.1 7.5 18.2 
AB-FUBINACA 19.3 17.9 5.2 
ADB-FUBINACA 6.5 20.0 18.0 
MDMB-CHMICA -19.7 -5.4 18.2 
MMB2201 19.8 13.6 17.3 
UR-144 -2.6 15.6 19.4 
 
3.3.5 MATRIX EFFECT 
Matrix effect (ME), process efficiency (PE) and recovery (R) results are summarised in Table 22. 
Matrix effects at 2 ng/mg ranged from 25 to 56%; at 1 ng/mg from 16 to 50%; and at the lowest point 
(0.5 ng/mg) from 14 to 45%. Process efficiency at the highest point (2 ng/mg) ranged from 19 to 
53%, at 1 ng/mg from 12 to 54%, and at the lowest point from 12 to 44%. Finally, recoveries at all 
concentrations were very good except for 5Cl-AB-PINACA at 0.5 ng/mg, which might be due to 
sampling error at said concentration. 
Table 22. Matrix effect, process efficiency, and recovery at three different concentrations: 2 ng/mg 
(high), 1 ng/mg (medium), and 0.5 ng/mg (low). 



























(R)-5F-ADB 53.7 53.1 99.0 16.0 12.2 75.9 37.0 33.9 91.6 
5F-PB 22 25.2 19.4 77.1 17.7 14.5 81.9 14.3 13.7 96.3 
5Cl-AB-PINACA 44.3 27.6 62.2 40.1 37.3 93.2 44.5 11.8 26.5 
5F-AKB48 40.7 36.4 89.6 14.2 16.9 118.8 14.6 12.6 86.6 
5F-APP-PICA (PX-
1) 
48.4 33.4 69.1 42.3 42.4 100.3 32.3 34.1 105.6 
5F-APP-PINACA 
(PX-2) 
46.0 33.7 73.4 38.2 44.3 116.1 41.6 38.2 91.9 
5F-CUMYL-PINACA 40.2 26.5 66.0 31.2 28.2 90.5 21.4 21.2 99.2 
AB-CHMINACA 46.5 45.6 98.2 30.1 33.8 112.4 30.6 29.5 96.4 
AB-FUBINACA 56.1 51.1 91.1 49.6 50.2 101.2 39.0 33.3 85.5 
ADB-FUBINACA 39.1 31.7 81.1 26.5 28.8 108.8 27.0 40.1 148.8 
MDMB-CHMICA 36.3 33.2 91.5 29.0 27.3 94.2 20.8 12.7 60.9 
MMB-2201 34.0 28.7 84.4 32.1 31.0 96.6 45.4 44.7 98.5 
UR-144 32.1 19.1 59.4 34.1 54.9 160.8 35.9 20.3 56.6 
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3.3.6 AUTHENTIC HAIR SAMPLES 
Real hair samples from patients that have tested positive for other illegal drugs (Table 23) were 
analysed. No information was available regarding the intake of SC from the patients. However, all 
samples tested negative for SCs. 
Table 23. Real hair samples obtained from 11 patients that have been tested for illegal drugs. 
Hair sample Positive for 
1 Cocaine, Benzodiazepine 
2 Cocaine, Benzodiazepine, morphine 
3 Cocaine, Benzodiazepine 
4 Cocaine, Benzodiazepine, Codeine 
5 Cocaine, Benzodiazepine 
6 Cocaine, Benzodiazepine, methadone 
7 Cocaine, Benzodiazepine 
8 Cocaine, Benzodiazepine 
9 Cocaine, Benzodiazepine 
10 Cocaine, Benzodiazepine, morphine, methadone 
11 Cocaine, Benzodiazepine, morphine, methadone 
 
3.4 CONCLUSION 
The developed LC–IonTrap methodology proved suitable for the screening of 13 second-wave 
synthetic cannabinoids: (R)-5F-ADB, 5F-PB 22, 5Cl-AB-PINACA, 5F-AKB48, 5F-APP-PICA (PX-1), 
5F-APP-PINACA (PX-2), 5F-CUMYL-PINACA, AB-CHMINACA, AB-FUBINACA, ADB-FUBINACA, 
MDMB-CHMICA, MMB-2201, and UR-144 in human hair samples. The method has a simple and 
effective sample treatment and presents good selectivity, linearity precision, and bias. It is high 







Abbreviations are not given in alphabetical order but by order of appearance.  
IR Infrared 
NMR Nuclear Magnetic Resonance 
GSR Gun Shot Residue 
SEM-EDS Scanning Electron Microscope with energy dispersive X-ray spectroscopy 
GC-MS/MS Gas Chromatography coupled with mass detection 
SERS Surface-Enhanced Raman Spectroscopy 
IMS Ion Mobility Spectrometry 
DNA Deoxyribonucleic acid 
NPS New Psychoactive Substances 
CE Capillary Electrophoresis 
PMI/PMIs Post-mortem interval/ Post-mortem intervals 
µm Micrometers 
ηL Nanoliters 
EOF Electroosmotic Flow 
CZE Capillary zone electrophoresis 
MEKC Micellar electrokinetic chromatography 
CGE Capillary gel electrophoresis 
CITP Capillary isotachophoresis 
CEC Capillary electrochromatography 
CDT Carbohydrate-Deficient Transferrin 
kNN k-nearest neighbour 
PLS-DA Partial-least-squares discriminant analysis 
ANN Artificial Neural Networks 
MLP Multilayer perceptron 
SGD Stochastic Gradient Descent 
Adam Adam: Stochastic Gradient Descent-based optimiser, 
L-BFGS Broyden–Fletcher–Goldfarb–Shanno 
IC Ion Chromatography 
HIBA α-hydroxybutyric acid 
UV Ultra-violet 
mM Millimolar 
V/cm Volts per centimetre 







psi Pounds per square inch 
M Molar 
NaOH Sodium hydroxide 
min Minutes 
IS Internal standard 
μg/mL Micrograms per millilitre 
RSD Relative Standard Deviation 
SWGTOX Scientific Woking Group for Forensic Toxicology 
LOD Limit of detection 
LOQ Limit of quantification 
SD Standard Deviation 
MAE Mean Absolute Error 
LC Liquid chromatography 
UV-Vis Ultraviolet-visible absorption 
DAD Diode Array 
FRTIR Fourier Transform Infrared 
MS Mass Spectrometry 
UPLC Ultra-Performance Liquid Chromatography 
m/z Mass-to-charge ratio 
ESI Electrospray Ionisation 
APPI Atmospheric Pressure Photoionisation 
APCI Atmospheric Pressure Chemical Photoionisation 
iB IonBoosterTM 
EI Electrical Ionisation 
CI Chemical Ionisation 
SCAN Scan mode 
SIM Selected Ion Monitoring 
amu Atomic mass units 
Q Quadrupole 
IT Ion Trap 
QQQ Triple quadrupole 
QTRAP Quadrupole Ion Trap 
TOF Time of flight 
QTOF Quadrupole TOF 
83 
 
AC Alternating current 
DC Direct current 
RF Radio Frequency 
LC-MS/MS Liquid chromatography coupled with tandem mass spectrometric detection 
SCs or SC Synthetic cannabinoids 
CB1 and CB2 Cannabinoid receptor type 1 and type 2 
THC Tetrahydrocannabinol 
EUEWS European Union Early Warning System 
EMCDDA European Monitoring Center for Drugs and Drug Addiction 
HLMs Human liver microsomes 
LC–QTOF-MS/MS 




v/v Volume per volume 
V Volts 
mL/min Millilitres per minute 
eV Electronvolts 
h Hours 
UHPLC Ultra-high-performance liquid chromatography 
mg Milligrams 
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6.1 APPENDIX I. NH4+ IN VITREOUS HUMOUR 
6.1.1 LIST OF VITREOUS HUMOUR SAMPLES USED FOR THE STUDY 
Table 24. List of vitreous humour samples, their electrophoresis data and ion concentrations used 
in the PMI interval evaluation. PA stands for Peak Area, PH stands for Peak Height. 













VH 1 1316 533 0.99 13700 6048 15.28 15016 6581 19326 6441 77.1 
VH 2 1410 539 1.01 13348 5693 14.03 14758 6232 20492 6762 47 
VH 3 1032 364 0.51 11677 4803 12.30 12709 5166 20399 6666 21.5 
VH 4 2495 602 1.36 34647 9937 24.47 37142 10539 30697 7615 143 
VH 5 1017 245 0.00 18775 5049 11.94 19792 5293 33774 8549 46 
VH 6 1915 719 1.49 22530 8433 22.01 24445 9152 22195 6397 87.15 
VH 7 929 400 0.03 6169 2800 4.67 7098 3201 27560 7293 17.15 
VH 8 2509 595 1.47 24187 9178 17.43 26696 9773 29554 7280 123.44 
VH 9 2757 583 1.20 42316 10580 25.11 45073 11164 36540 8362 143 
VH 10 727 391 0.39 6520 3631 8.62 7247 4023 16140 5615 32 
VH 11 1155 496 0.97 13131 5928 16.47 14286 6424 17202 5775 56.05 
VH 12 773 344 0.38 11576 5284 14.95 12348 5628 16686 5443 52 
VH 13 2172 788 2.29 23883 9210 27.23 26056 9999 19030 6188 168.5 
VH 14 787 291 0.00 8610 3494 7.27 9398 3785 25119 6854 16.1 
VH 15 1490 484 0.60 17338 6309 13.56 18828 6794 27512 7262 47.4 
VH 16 1780 578 1.49 20349 7574 21.18 22129 8152 20793 6636 100.3 
VH 17 1027 308 0.08 19201 6411 14.33 20228 6719 28896 6713 68 
VH 18 713 332 0.35 6028 2786 8.04 6741 3118 15855 5122 29 
VH 19 3768 1067 3.10 31437 10213 25.95 35205 11280 26275 7481 163.2 
VH 20 2299 703 1.38 24644 8483 18.98 26943 9186 28090 7709 96.45 
VH 21 2421 684 1.42 18290 7434 17.43 20711 8118 12409 7151 52.3 
VH 22 3825 901 2.14 43168 11870 23.66 46993 12771 35130 8535 99.45 
VH 23 1643 562 0.82 20230 7825 16.43 21873 8387 26578 7346 98.45 
VH 24 1699 594 1.06 22439 8786 20.11 24138 9380 24115 7128 99.16 
VH 25 4121 1198 2.98 32412 10812 23.73 36533 12011 29643 7717 144.23 
VH 26 1284 428 0.38 14012 5096 10.75 15296 5524 27918 7564 25 
VH 27 1087 345 0.14 19104 6643 14.08 20191 6989 29176 7117 46.24 
VH 28 908 378 0.04 13229 5610 10.66 14137 5988 26594 6908 23.35 
VH 29 654 272 0.00 10899 4687 9.03 11552 4958 25797 6920 17.55 
VH 30 1802 693 0.99 22586 9142 18.39 24388 9835 26533 7126 48.4 
VH 31 1482 578 0.59 20377 8492 15.86 21859 9070 27709 7276 48.4 
VH 32 1377 540 0.56 16614 7181 13.67 17990 7721 26173 6943 50.15 
VH 33 1198 409 0.24 22060 8668 16.33 23258 9077 29208 7605 71.15 
VH 34 1777 547 1.23 22563 7869 20.58 24340 8416 23416 6243 48.45 
VH 35 2015 804 2.27 14241 6392 17.37 16256 7195 17763 5273 38.3 
VH 36 416 157 0.00 7517 3023 5.74 7933 3180 27657 7184 6.55 
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VH 37 1371 564 0.91 18031 8036 18.51 19402 8600 21135 6326 75.5 
VH 38 978 446 1.02 14441 7205 17.58 15419 7651 19697 5753 27.35 
Pink samples were used for the preliminary linear approach together with two more (a total of 14) but those 
two were later removed for further analysis since they were overdoses. For the logarithmic approach all 
samples except the blue ones (a total of 33) were used. For the neural networks, the same samples as the 
logarithmic approach and the blue ones were used (total of 38). 
6.1.2 TRAIN TEST SPLIT AND DATA PRE-PROCESSING 
import matplotlib.pyplot as plt 
import pandas as pd 
from sklearn import neighbors, datasets, preprocessing  
from sklearn.model_selection import train_test_split 
from sklearn.neural_network import MLPRegressor 
from sklearn.metrics import r2_score 
from sklearn.metrics import mean_squared_error 
from sklearn.metrics import mean_absolute_error 
 
vhdata = pd.read_csv('vhrawdata.csv') 
X = vhdata[['CNH4', 'CK', 'rNA']] 
y = vhdata['PMI'] 
X_train, X_test, y_train, y_test = train_test_split(X, y, random_state=0)  
 
from sklearn.preprocessing import MinMaxScaler 
scaler = MinMaxScaler() 
X_train_norm = scaler.fit_transform(X_train) 
X_test_norm = scaler.transform(X_test) 
6.1.3 CODE FOR ADAM SOLVER 
6.1.3.1 NUMBER OF NODES IN THE HIDDEN LAYER 
for hn in [1,2,3,4,5,6,7,8,9,10]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,hn), activation = 'logistic',                   
ssssssssssssolver = 'adam', alpha = 0.1, max_iter=400000,random_state=0) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with {} nodes: {:.3f}'.format(hn,           
xxxx r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} nodes:{:.3f}'.format(hn, xxxx 
xxxxr2_score(y_test,y_test_prediction))) 
     
    print('Mean Absolute error Train (MSE) with {} nodes: {:.3f}'.format(hn, 
xxxx mean_absolute_error(y_train, y_train_prediction))) 
    print('Mean Absolute error Test (MAE) with {} nodes: {:.3f}'.format(hn, xxxx 
xxxxmean_absolute_error(y_test, y_test_prediction))) 
 
Training set prediction (R2 score) with 1 nodes: -0.000 
Test set prediction (R2 score) with 1 nodes:-0.010 
Mean Absolute error Train (MSE) with 1 nodes: 32.114 
Mean Absolute error Test (MSE) with 1 nodes: 45.678 
Training set prediction (R2 score) with 2 nodes: -0.000 
Test set prediction (R2 score) with 2 nodes:-0.010 
Mean Absolute error Train (MSE) with 2 nodes: 32.118 
Mean Absolute error Test (MSE) with 2 nodes: 45.678 
Training set prediction (R2 score) with 3 nodes: -0.000 
Test set prediction (R2 score) with 3 nodes:-0.010 
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Mean Absolute error Train (MSE) with 3 nodes: 32.123 
Mean Absolute error Test (MSE) with 3 nodes: 45.678 
Training set prediction (R2 score) with 4 nodes: 0.860 
Test set prediction (R2 score) with 4 nodes:0.701 
Mean Absolute error Train (MSE) with 4 nodes: 11.424 
Mean Absolute error Test (MSE) with 4 nodes: 21.667 
Training set prediction (R2 score) with 5 nodes: 0.859 
Test set prediction (R2 score) with 5 nodes:0.696 
Mean Absolute error Train (MSE) with 5 nodes: 11.458 
Mean Absolute error Test (MSE) with 5 nodes: 21.832 
Training set prediction (R2 score) with 6 nodes: 0.858 
Test set prediction (R2 score) with 6 nodes:0.694 
Mean Absolute error Train (MSE) with 6 nodes: 11.483 
Mean Absolute error Test (MSE) with 6 nodes: 21.911 
Training set prediction (R2 score) with 7 nodes: 0.857 
Test set prediction (R2 score) with 7 nodes:0.693 
Mean Absolute error Train (MSE) with 7 nodes: 11.446 
Mean Absolute error Test (MSE) with 7 nodes: 22.070 
Training set prediction (R2 score) with 8 nodes: 0.858 
Test set prediction (R2 score) with 8 nodes:0.693 
Mean Absolute error Train (MSE) with 8 nodes: 11.436 
Mean Absolute error Test (MSE) with 8 nodes: 22.072 
Training set prediction (R2 score) with 9 nodes: 0.856 
Test set prediction (R2 score) with 9 nodes:0.690 
Mean Absolute error Train (MSE) with 9 nodes: 11.449 
Mean Absolute error Test (MSE) with 9 nodes: 22.188 
Training set prediction (R2 score) with 10 nodes: 0.856 
Test set prediction (R2 score) with 10 nodes:0.690 
Mean Absolute error Train (MSE) with 10 nodes: 11.449 
Mean Absolute error Test (MSE) with 10 nodes: 22.189 
 
6.1.3.2  ACTIVATION FUNCTION 
for actfun in ['identity','logistic','tanh','relu']: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = actfun, solver 
xxxx= 'adam', alpha = 0.1, max_iter=400000, random_state=0) 
     
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with {} activation function: xxxx 
xxxx{:.3f}'.format(actfun, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} activation function: xxxx xxxx 
xxxx{:.3f}'.format(actfun, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with identity activation function: 0.753 
Test set prediction (R2 score) with identity activation function:0.820 
Training set prediction (R2 score) with logistic activation function: 0.860 
Test set prediction (R2 score) with logistic activation function:0.701 
Training set prediction (R2 score) with tanh activation function: 0.879 
Test set prediction (R2 score) with tanh activation function:0.673 
Training set prediction (R2 score) with relu activation function: 0.776 
Test set prediction (R2 score) with relu activation function:0.803 
 
6.1.3.3  ALPHA VALUE 
for alphavalue in [0.1, 0.01, 0.001, 0.2, 0.3]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = 'logistic',   -
---------------------   solver = 'adam', alpha = alphavalue,   
xxxxxxxxxxxxxxxxxxxxxxlearning_rate_init=0.001, max_iter=400000, random_state=0) 
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    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with alpha= {}:{:.3f}'.format 
xxxx(alphavalue, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with alpha= {}:{:.3f}'.format 
xxxx(alphavalue, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with alpha= 0.1 : 0.860 
Test set prediction (R2 score) with alpha= 0.1 :0.701 
Training set prediction (R2 score) with alpha= 0.01 : 0.874 
Test set prediction (R2 score) with alpha= 0.01 :0.678 
Training set prediction (R2 score) with alpha= 0.001 : 0.877 
Test set prediction (R2 score) with alpha= 0.001 :0.667 
Training set prediction (R2 score) with alpha= 0.2 : 0.850 
Test set prediction (R2 score) with alpha= 0.2 :0.711 
Training set prediction (R2 score) with alpha= 0.3 : -0.000 
Test set prediction (R2 score) with alpha= 0.3 :-0.010 
 
6.1.3.4 LEARNING RATE (DEFAULT=0.001) 
for lr in [0.0001,0.001,0.01,0.1,0.2,0.3,0.4,0.5,0.6,0.7]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = 'logistic',   -
---------------------   solver = 'adam', alpha = 0.1,   
xxxxxxxxxxxxxxxxxxxxxxxxlearning_rate_init=lr, max_iter=400000, random_state=0)    
xxxxnnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with learning rate={}:{:.3f}'. 
xxxxformat (lr, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with learning rate={}:{:.3f}'.format 
xxxx(lr, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with learning rate= 0.0001 : -0.000 
Test set prediction (R2 score) with learning rate= 0.0001 :-0.011 
Training set prediction (R2 score) with learning rate= 0.001 : 0.860 
Test set prediction (R2 score) with learning rate= 0.001 :0.701 
Training set prediction (R2 score) with learning rate= 0.01 : 0.861 
Test set prediction (R2 score) with learning rate= 0.01 :0.700 
Training set prediction (R2 score) with learning rate= 0.1 : 0.818 
Test set prediction (R2 score) with learning rate= 0.1 :0.712 
Training set prediction (R2 score) with learning rate= 0.2 : -0.000 
Test set prediction (R2 score) with learning rate= 0.2 :-0.008 
Training set prediction (R2 score) with learning rate= 0.3 : -0.001 
Test set prediction (R2 score) with learning rate= 0.3 :-0.004 
Training set prediction (R2 score) with learning rate= 0.4 : -0.009 
Test set prediction (R2 score) with learning rate= 0.4 :-0.000 
Training set prediction (R2 score) with learning rate= 0.5 : -0.023 
Test set prediction (R2 score) with learning rate= 0.5 :-0.001 
Training set prediction (R2 score) with learning rate= 0.6 : -0.042 
Test set prediction (R2 score) with learning rate= 0.6 :-0.006 
Training set prediction (R2 score) with learning rate= 0.7 : -0.060 
Test set prediction (R2 score) with learning rate= 0.7 :-0.012 
6.1.3.5  RANDOM SEED IN THE MLPREGRESSOR 
for numrs in [0,17,25,28,88,99]: 
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    nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = 'logistic',    
xxxxxxxxxxxxxxxxxxxxxxxxsolver = 'adam', alpha = 0.1, max_iter=400000, 
                        random_state= numrs) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with random state {} : {:.3f}'. 
xxxxformat(numrs, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with random state {} :{:.3f}'. 
xxxxformat(numrs, r2_score(y_test,y_test_prediction))) 
Training set prediction (R2 score) with random state 0 : 0.860 
Test set prediction (R2 score) with random state 0 :0.701 
Training set prediction (R2 score) with random state 17 : 0.860 
Test set prediction (R2 score) with random state 17 :0.701 
Training set prediction (R2 score) with random state 25 : 0.860 
Test set prediction (R2 score) with random state 25 :0.701 
Training set prediction (R2 score) with random state 28 : 0.860 
Test set prediction (R2 score) with random state 28 :0.700 
Training set prediction (R2 score) with random state 88 : 0.860 
Test set prediction (R2 score) with random state 88 :0.701 
Training set prediction (R2 score) with random state 99 : 0.860 
Test set prediction (R2 score) with random state 99 :0.701 
6.1.3.6  VALIDATION 
from sklearn.model_selection import cross_val_score 
from sklearn.model_selection import LeaveOneOut 
 
from numpy import mean 
from numpy import std 




X = vhdata[['CNH4', 'CK', 'rNA']] 
y = vhdata['PMI'] 
X_train, X_test, y_train, y_test = train_test_split(X, y, random_state=77*) 
 
from sklearn.preprocessing import MinMaxScaler 
scaler = MinMaxScaler() 
X_train_norm = scaler.fit_transform(X_train) 
X_test_norm = scaler.transform(X_test) 
 
nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = 'logistic', solver 




cv = KFold(n_splits=5, shuffle=True) 
scores = cross_val_score(nnvh, X, y, cv=cv, n_jobs=-1) 
 
print('Cross-validation score (5-fold): ', scores)) 
print('Accuracy: %.2f (%.2f)' % (mean(scores), std(scores))) 
 
cv = LeaveOneOut() 
# evaluate model 
scores = cross_val_score(nnvh, X, y, scoring='neg_mean_absolute_error', cv=cv, 
n_jobs=-1) 
# force positive 
scores = absolute(scores) 
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# report performance 
print('MAE: %.3f' % (mean(scores))) 
 
 
Cross-validation score (5-fold)): [0.75739 0.72023 0.9021909 0.88255 0.8
2953] 
Accuracy: 0.82 (0.08) 
MAE: 18.485 
 
6.1.3.7 FINAL NETWORK 
X = vhdata[['CNH4', 'CK', 'rNA']] 
y = vhdata['PMI'] 
X_train, X_test, y_train, y_test = train_test_split(X, y, random_state=1) 
 
from sklearn.preprocessing import MinMaxScaler 
scaler = MinMaxScaler() 
X_train_norm = scaler.fit_transform(X_train) 
X_test_norm = scaler.transform(X_test) 
 
nnvh = MLPRegressor(hidden_layer_sizes = (1,4), activation = 'logistic', solver 








plt.scatter(y_train,y_train_prediction, marker = 'o', color='grey') 
plt.xlabel('PMI expected (hrs)') 
plt.ylabel('PMI predicted (hrs)') 
plt.title('Correlation of PMI predicted by MLPregressor with the real PMI 
(Training set)') 
plt.show() 
print('Training set prediction (R2 score): 
{:.3f}'.format(r2_score(y_train,y_train_prediction))) 
print('Mean Squared error Train (MSE): 
{:.3f}'.format(mean_squared_error(y_train, y_train_prediction))) 




plt.scatter(y_test,y_test_prediction, marker = 'o', color='blue') 
plt.xlabel('PMI expected (hrs)') 
plt.ylabel('PMI predicted (hrs)') 
plt.title('Correlation of PMI predicted by MLPregressor with the real PMI (Test 
set)') 
plt.show() 
print('Test set prediction (R2 score): 
{:.3f}'.format(r2_score(y_test,y_test_prediction))) 
print('Mean Squared error Test (MSE): {:.3f}'.format(mean_squared_error(y_test, 
y_test_prediction))) 












##For getting the predictions of the Train/Test split## 
print('Train/Test predictions') 
 
for j in range(y_test_prediction.shape[0]):print('{} {}{}'.format 
xxx(y_test.index[j],y_test[y_test.index[j]],y_test_prediction[j])) 








6.1.4 CODE FOR SGD SOLVER 
6.1.4.1 NUMBER OF NODES IN THE HIDDEN LAYER 
for hn in [1,2,3,4,5,6,7,8,9,10]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,hn), activation = 'logistic', 
dddddddddd              solver = 'sgd', alpha = 0.1, learning_rate= 'constant', 
                        learning_rate_init= 0.001, max_iter=400000,    
xxxxxxxxxxxxxxxxxxxxxxxxrandom_state=0, momentum= 0.3, nesterovs_momentum= 
xxxxxxxxxxxxxxxxxxxxxxxxFalse) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
          
    print('Training set prediction (R2 score) with {} nodes: {:.3f}'.format(hn, 
xxxxr2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} nodes:{:.3f}'.format(hn, 
xxxxr2_score(y_test,y_test_prediction))) 
     
    print('Mean Absolute error Train (MSE) with {} nodes: {:.3f}'.format(hn, 
xxxxmean_absolute_error(y_train, y_train_prediction))) 
    print('Mean Absolute error Test (MSE) with {} nodes: {:.3f}'.format(hn, 
xxxxmean_absolute_error(y_test, y_test_prediction))) 
Training set prediction (R2 score) with 1 nodes: 0.629 
Test set prediction (R2 score) with 1 nodes:0.648 
Mean Absolute error Train (MSE) with 1 nodes: 19.231 
Mean Absolute error Test (MSE) with 1 nodes: 28.079 
Training set prediction (R2 score) with 2 nodes: 0.796 
Test set prediction (R2 score) with 2 nodes:0.706 
Mean Absolute error Train (MSE) with 2 nodes: 13.842 
Mean Absolute error Test (MSE) with 2 nodes: 23.130 
Training set prediction (R2 score) with 3 nodes: 0.000 
Test set prediction (R2 score) with 3 nodes:-0.007 
Mean Absolute error Train (MSE) with 3 nodes: 32.258 
Mean Absolute error Test (MSE) with 3 nodes: 45.670 
Training set prediction (R2 score) with 4 nodes: -0.001 
Test set prediction (R2 score) with 4 nodes:-0.004 
Mean Absolute error Train (MSE) with 4 nodes: 32.484 
Mean Absolute error Test (MSE) with 4 nodes: 45.670 
Training set prediction (R2 score) with 5 nodes: -0.003 
Test set prediction (R2 score) with 5 nodes:-0.001 
Mean Absolute error Train (MSE) with 5 nodes: 32.745 
Mean Absolute error Test (MSE) with 5 nodes: 45.667 
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Training set prediction (R2 score) with 6 nodes: -0.008 
Test set prediction (R2 score) with 6 nodes:0.000 
Mean Absolute error Train (MSE) with 6 nodes: 33.107 
Mean Absolute error Test (MSE) with 6 nodes: 45.666 
Training set prediction (R2 score) with 7 nodes: -0.014 
Test set prediction (R2 score) with 7 nodes:0.001 
Mean Absolute error Train (MSE) with 7 nodes: 33.415 
Mean Absolute error Test (MSE) with 7 nodes: 45.664 
Training set prediction (R2 score) with 8 nodes: -0.020 
Test set prediction (R2 score) with 8 nodes:0.000 
Mean Absolute error Train (MSE) with 8 nodes: 33.752 
Mean Absolute error Test (MSE) with 8 nodes: 45.655 
Training set prediction (R2 score) with 9 nodes: -0.027 
Test set prediction (R2 score) with 9 nodes:-0.001 
Mean Absolute error Train (MSE) with 9 nodes: 34.112 
Mean Absolute error Test (MSE) with 9 nodes: 45.646 
Training set prediction (R2 score) with 10 nodes: -0.034 
Test set prediction (R2 score) with 10 nodes:-0.002 
Mean Absolute error Train (MSE) with 10 nodes: 34.392 
Mean Absolute error Test (MSE) with 10 nodes: 45.636 
 
6.1.4.2 ACTIVATION FUNCTION 
for actfun in ['identity','logistic','tanh','relu']: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = actfun, solver 
xxxxxxxxxxxxxxxxxxxxxxxx= 'sgd', alpha = 0.1, learning_rate= 'constant', 
                        learning_rate_init= 0.001, max_iter=400000, 
xxxxxxxxxxxxxxxxxxxxxxxxrandom_state=0, momentum= 0.3, nesterovs_momentum= 
xxxxxxxxxxxxxxxxxxxxxxxxFalse) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with {} activation function: 
xxxx{:.3f}'.format(actfun, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} activation 
xxxxfunction:{:.3f}'.format(actfun, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with identity activation function: 0.753 
Test set prediction (R2 score) with identity activation function:0.820 
Training set prediction (R2 score) with logistic activation function: 0.796 
Test set prediction (R2 score) with logistic activation function:0.706 
Training set prediction (R2 score) with tanh activation function: 0.587 
Test set prediction (R2 score) with tanh activation function:0.680 
Training set prediction (R2 score) with relu activation function: 0.730 
Test set prediction (R2 score) with relu activation function:0.755 
 
6.1.4.3 ALPHA VALUE 
for alphavalue in [0.1, 0.01, 0.001, 0.2, 0.3]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = 'logistic', 
xxxxxxxxxxxxxxxxxxxxxxxxsolver = 'sgd', alpha = alphavalue, learning_rate= 
xxxxxxxxxxxxxxxxxxxxxxxx'constant', learning_rate_init= 0.001, max_iter=400000, 
xxxxxxxxxxxxxxxxxxxxxxxxrandom_state=0, momentum= 0.3, nesterovs_momentum= 
xxxxxxxxxxxxxxxxxxxxxxxxFalse) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
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    print('Training set prediction (R2 score) with alpha= {} : 
xxxx{:.3f}'.format(alphavalue, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with alpha= {} 
xxxx:{:.3f}'.format(alphavalue, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with alpha= 0.1 : 0.796 
Test set prediction (R2 score) with alpha= 0.1 :0.706 
Training set prediction (R2 score) with alpha= 0.01 : 0.794 
Test set prediction (R2 score) with alpha= 0.01 :0.740 
Training set prediction (R2 score) with alpha= 0.001 : 0.794 
Test set prediction (R2 score) with alpha= 0.001 :0.694 
Training set prediction (R2 score) with alpha= 0.2 : 0.797 
Test set prediction (R2 score) with alpha= 0.2 :0.742 
Training set prediction (R2 score) with alpha= 0.3 : 0.796 
Test set prediction (R2 score) with alpha= 0.3 :0.730 
 
6.1.4.4 LEARNING RATE 
for lr in [0.0001,0.001,0.01,0.1,0.2,0.3,0.4,0.5,0.6,0.7]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = 'logistic', 
xxxxxxxxxxxxxxxxxxxxxxxxsolver = 'sgd', alpha = 0.01, learning_rate= 'constant', 
                        learning_rate_init= lr, max_iter=400000, 
xxxxxxxxxxxxxxxxxxxxxxxxrandom_state=0, momentum= 0.3, nesterovs_momentum= 
xxxxxxxxxxxxxxxxxxxxxxxxFalse) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with learning rate= {}:{:.3f}'. 
xxxxformat(lr, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with learning rate= {}:{:.3f}'. xxxx 
xxxxformat(lr, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with learning rate= 0.0001 : 0.811 
Test set prediction (R2 score) with learning rate= 0.0001 :0.722 
Training set prediction (R2 score) with learning rate= 0.001 : 0.816 
Test set prediction (R2 score) with learning rate= 0.001 :0.712 
Training set prediction (R2 score) with learning rate= 0.01 : 0.498 
Test set prediction (R2 score) with learning rate= 0.01 :0.628 
Training set prediction (R2 score) with learning rate= 0.1 : 0.000 
Test set prediction (R2 score) with learning rate= 0.1 :-0.009 
Training set prediction (R2 score) with learning rate= 0.2 : 0.000 
Test set prediction (R2 score) with learning rate= 0.2 :-0.009 
Training set prediction (R2 score) with learning rate= 0.3 : -0.000 
Test set prediction (R2 score) with learning rate= 0.3 :-0.009 
Training set prediction (R2 score) with learning rate= 0.4 : -0.000 
Test set prediction (R2 score) with learning rate= 0.4 :-0.009 
Training set prediction (R2 score) with learning rate= 0.5 : -0.000 
Test set prediction (R2 score) with learning rate= 0.5 :-0.009 
Training set prediction (R2 score) with learning rate= 0.6 : -0.000 
Test set prediction (R2 score) with learning rate= 0.6 :-0.009 
Training set prediction (R2 score) with learning rate= 0.7 : -0.000 
Test set prediction (R2 score) with learning rate= 0.7 :-0.009 
 
6.1.4.5 MOMENTUM 
for m in [0.01,0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = 'logistic', 
xxxx xxxx xxxx xxxx xxx solver = 'sgd', alpha = 0.01, learning_rate= 'constant', 
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                         learning_rate_init= 0.001, max_iter=400000, xxxx xxxx 
xxxx xxxx xxxx xxxx xxxx random_state=0, momentum= m, nesterovs_momentum= False) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with momentum= {}:{:.3f}'. format 
xxxx(m, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with momentum={}:{:.3f}'.format     
xxxx(m,r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with momentum= 0.01 : 0.811 
Test set prediction (R2 score) with momentum= 0.01 :0.723 
Training set prediction (R2 score) with momentum= 0.1 : 0.813 
Test set prediction (R2 score) with momentum= 0.1 :0.718 
Training set prediction (R2 score) with momentum= 0.2 : 0.814 
Test set prediction (R2 score) with momentum= 0.2 :0.715 
Training set prediction (R2 score) with momentum= 0.3 : 0.816 
Test set prediction (R2 score) with momentum= 0.3 :0.712 
Training set prediction (R2 score) with momentum= 0.4 : 0.817 
Test set prediction (R2 score) with momentum= 0.4 :0.711 
Training set prediction (R2 score) with momentum= 0.5 : 0.818 
Test set prediction (R2 score) with momentum= 0.5 :0.708 
Training set prediction (R2 score) with momentum= 0.6 : 0.819 
Test set prediction (R2 score) with momentum= 0.6 :0.701 
Training set prediction (R2 score) with momentum= 0.7 : 0.820 
Test set prediction (R2 score) with momentum= 0.7 :0.698 
Training set prediction (R2 score) with momentum= 0.8 : 0.821 
Test set prediction (R2 score) with momentum= 0.8 :0.699 
Training set prediction (R2 score) with momentum= 0.9 : 0.821 
Test set prediction (R2 score) with momentum= 0.9 :0.687 
 
6.1.4.6 NESTEROVS MOMENTUM 
nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = 'logistic', solver 
= 'sgd', alpha = 0.01, learning_rate= 'constant', 





        
print('Training set prediction (R2 score) with nesterovs momentum : 
{:.3f}'.format(r2_score(y_train,y_train_prediction))) 
print('Test set prediction (R2 score) with nesterovs momentum 
:{:.3f}'.format(r2_score(y_test,y_test_prediction))) 
     
Training set prediction (R2 score) with nesterovs momentum : 0.794 
Test set prediction (R2 score) with nesterovs momentum :0.740 
6.1.4.7  RANDOM STATE MLPREGRESSOR 
for numrs in [0,17,25,28,88,99]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,2), activation = 'logistic',    
xxxx xxxx xxxx xxxx xxxxsolver = 'sgd', alpha = 0.01, learning_rate= 'constant', 
xxxx xxxx xxxx xxxx xxxxlearning_rate_init= 0.001, max_iter=400000, xxxx xxxx 
xxxx xxxx xxxx xxxx xxxxrandom_state=numrs, momentum= 0.4, nesterovs_momentum=  
False) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
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    print('Training set prediction (R2 score) with random state {}:{:.3f}'. xxxx 
xxxxformat(numrs, r2_score(y_train,y_train_prediction))) 




Training set prediction (R2 score) with random state 0 : 0.816 
Test set prediction (R2 score) with random state 0 :0.712 
Training set prediction (R2 score) with random state 17 : 0.816 
Test set prediction (R2 score) with random state 17 :0.712 
Training set prediction (R2 score) with random state 25 : 0.816 
Test set prediction (R2 score) with random state 25 :0.712 
Training set prediction (R2 score) with random state 28 : 0.816 
Test set prediction (R2 score) with random state 28 :0.712 
Training set prediction (R2 score) with random state 88 : 0.816 
Test set prediction (R2 score) with random state 88 :0.712 
Training set prediction (R2 score) with random state 99 : 0.816 
Test set prediction (R2 score) with random state 99 :0.711 
6.1.5 CODE FOR LBFGS 
6.1.5.1 NUMBER OF NODES IN THE HIDDEN LAYER 
for hn in [1,2,3,4,5,6,7,8,9,10]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,hn), activation = 'logistic', 
xxxx                    solver = 'lbfgs', alpha = 0.1, max_iter=400000, 
                        random_state=0) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with {} nodes: {:.3f}'.format(hn, 
xxxxr2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} nodes:{:.3f}'.format(hn, xxxx 
xxxxr2_score(y_test,y_test_prediction))) 
    print('Mean Absolute error Train (MSE) with {} nodes: {:.3f}'.format(hn, 
xxxxmean_absolute_error(y_train, y_train_prediction))) 
    print('Mean Absolute error Test (MSE) with {} nodes: {:.3f}'.format(hn, xxxx 
xxxxmean_absolute_error(y_test, y_test_prediction))) 
     
Training set prediction (R2 score) with 1 nodes: 0.786 
Test set prediction (R2 score) with 1 nodes:0.710 
Mean Absolute error Train (MAE) with 1 nodes: 13.612 
Mean Absolute error Test (MAE) with 1 nodes: 23.232 
Training set prediction (R2 score) with 2 nodes: 0.822 
Test set prediction (R2 score) with 2 nodes:0.700 
Mean Absolute error Train (MAE) with 2 nodes: 12.138 
Mean Absolute error Test (MAE) with 2 nodes: 22.235 
Training set prediction (R2 score) with 3 nodes: 0.813 
Test set prediction (R2 score) with 3 nodes:0.747 
Mean Absolute error Train (MAE) with 3 nodes: 12.681 
Mean Absolute error Test (MAE) with 3 nodes: 20.407 
Training set prediction (R2 score) with 4 nodes: -0.000 
Test set prediction (R2 score) with 4 nodes:-0.009 
Mean Absolute error Train (MAE) with 4 nodes: 32.180 
Mean Absolute error Test (MAE) with 4 nodes: 45.678 
Training set prediction (R2 score) with 5 nodes: -0.000 
Test set prediction (R2 score) with 5 nodes:-0.009 
Mean Absolute error Train (MAE) with 5 nodes: 32.180 
Mean Absolute error Test (MAE) with 5 nodes: 45.678 
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Training set prediction (R2 score) with 6 nodes: 0.861 
Test set prediction (R2 score) with 6 nodes:0.692 
Mean Absolute error Train (MAE) with 6 nodes: 11.388 
Mean Absolute error Test (MAE) with 6 nodes: 21.968 
Training set prediction (R2 score) with 7 nodes: 0.861 
Test set prediction (R2 score) with 7 nodes:0.691 
Mean Absolute error Train (MAE) with 7 nodes: 11.390 
Mean Absolute error Test (MAE) with 7 nodes: 21.985 
Training set prediction (R2 score) with 8 nodes: 0.861 
Test set prediction (R2 score) with 8 nodes:0.692 
Mean Absolute error Train (MAE) with 8 nodes: 11.390 
Mean Absolute error Test (MAE) with 8 nodes: 21.978 
Training set prediction (R2 score) with 9 nodes: 0.896 
Test set prediction (R2 score) with 9 nodes:0.716 
Mean Absolute error Train (MAE) with 9 nodes: 10.576 
Mean Absolute error Test (MAE) with 9 nodes: 21.210 
Training set prediction (R2 score) with 10 nodes: 0.860 
Test set prediction (R2 score) with 10 nodes:0.690 
Mean Absolute error Train (MAE) with 10 nodes: 11.408 
Mean Absolute error Test (MAE) with 10 nodes: 22.013 
6.1.5.2 ACTIVATION FUNCTION 
for actfun in ['identity','logistic','tanh','relu']: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,3), activation = actfun, solver 
xxxx xxxx xxxx xxxx xxxx = 'lbfgs', alpha = 0.1, max_iter=400000, 
                        random_state=0) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with {} activation function: xxxx 
xxxx{:.3f}'. format(actfun, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with {} activation function:{:.3f}'. 
xxxxformat(actfun, r2_score(y_test,y_test_prediction))) 
     
 
Training set prediction (R2 score) with identity activation function: 0.753 
Test set prediction (R2 score) with identity activation function:0.820 
Training set prediction (R2 score) with logistic activation function: 0.813 
Test set prediction (R2 score) with logistic activation function:0.747 
Training set prediction (R2 score) with tanh activation function: 0.485 
Test set prediction (R2 score) with tanh activation function:0.398 
Training set prediction (R2 score) with relu activation function: 0.777 
Test set prediction (R2 score) with relu activation function:0.803 
6.1.5.3 ALPHA VALUE 
for alphavalue in [0.1, 0.01, 0.001, 0.2, 0.3]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,3), activation = 'logistic', 
xxxx xxxx xxxx xxxx xxxxsolver = 'lbfgs', alpha = alphavalue, max_iter=400000, 
                        random_state=0) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with alpha= {} : {:.3f}'. xxxx 
xxxxformat(alphavalue, r2_score(y_train,y_train_prediction))) 





Training set prediction (R2 score) with alpha= 0.1 : 0.813 
Test set prediction (R2 score) with alpha= 0.1 :0.747 
Training set prediction (R2 score) with alpha= 0.01 : 0.828 
Test set prediction (R2 score) with alpha= 0.01 :0.358 
Training set prediction (R2 score) with alpha= 0.001 : 0.881 
Test set prediction (R2 score) with alpha= 0.001 :0.656 
Training set prediction (R2 score) with alpha= 0.2 : 0.819 
Test set prediction (R2 score) with alpha= 0.2 :0.710 
Training set prediction (R2 score) with alpha= 0.3 : 0.816 
Test set prediction (R2 score) with alpha= 0.3 :0.724 
 
6.1.5.4 RANDOM STATE MLPREGRESSOR  
for numrs in [0,17,25,28,88,99]: 
    nnvh = MLPRegressor(hidden_layer_sizes = (1,3), activation = 'logistic', 
xxxx xxxx xxxx xxxx xxxxsolver = 'lbfgs', alpha = 0.1, max_iter=400000, 
                        random_state= numrs) 
    nnvh.fit(X_train_norm, y_train) 
    y_train_prediction= nnvh.predict(X_train_norm) 
    y_test_prediction= nnvh.predict(X_test_norm) 
        
    print('Training set prediction (R2 score) with random state {} : {:.3f}'. 
xxxxformat(numrs, r2_score(y_train,y_train_prediction))) 
    print('Test set prediction (R2 score) with random state {} :{:.3f}'. xxxx 
xxxxformat(numrs, r2_score(y_test,y_test_prediction))) 
 
Training set prediction (R2 score) with random state 0 : 0.813 
Test set prediction (R2 score) with random state 0 :0.747 
Training set prediction (R2 score) with random state 17 : 0.785 
Test set prediction (R2 score) with random state 17 :0.710 
Training set prediction (R2 score) with random state 25 : 0.785 
Test set prediction (R2 score) with random state 25 :0.710 
Training set prediction (R2 score) with random state 28 : 0.824 
Test set prediction (R2 score) with random state 28 :0.403 
Training set prediction (R2 score) with random state 88 : 0.785 
Test set prediction (R2 score) with random state 88 :0.710 
Training set prediction (R2 score) with random state 99 : 0.824 
Test set prediction (R2 score) with random state 99 :0.402 
 
6.1.6 CODE FOR UNTRAINED REAL SAMPLE PREDICTIONS  
vhdatapred = pd.read_csv('vhrawdatapredictions5.csv')* 
X = vhdatapred[['PA NH4', 'PH NH4', 'PA K', 'PH K', 'PA NH4 + PA K', 'PH NH4 + 
PH K', 'PA IS', 'PH IS']] 
 
from sklearn.preprocessing import MinMaxScaler 
scaler = MinMaxScaler() 




for j in range(y_prediction_pmi.shape[0]): 
   print('{}'.format(y_prediction_pmi[j])) 
*The file with the inputs (X) 
For each random seed (1, 77, 34, 99, 70, 88, 100), this code is written afterwards to predict the 
untrained samples in each network.  
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6.2 APPENDIX II. ELUCIDATION OF THE 5F- APINAC METABOLIC PATHWAY 
6.2.1 EXTRACTED ION CHROMATOGRAMS FOR THE METABOLITES ASSOCIATED WITH 
5F-APINAC FOUND IN VITRO AND IN VIVO 
 




Supplementary Figure 2: Chromatograms for the metabolites associated to 5F-APINAC found in vivo. Panel 
A: 3 hours after drug administration. Panel B: 6 hours after drug administration 
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